EP1379549A2 - Genomsequenz des photorhabdus luminescens stamms tt01 und verwendungen - Google Patents
Genomsequenz des photorhabdus luminescens stamms tt01 und verwendungenInfo
- Publication number
- EP1379549A2 EP1379549A2 EP20020751498 EP02751498A EP1379549A2 EP 1379549 A2 EP1379549 A2 EP 1379549A2 EP 20020751498 EP20020751498 EP 20020751498 EP 02751498 A EP02751498 A EP 02751498A EP 1379549 A2 EP1379549 A2 EP 1379549A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- seq
- escherichia coli
- polypeptide
- protein
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241001148064 Photorhabdus luminescens Species 0.000 title claims abstract description 167
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 236
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 217
- 229920001184 polypeptide Polymers 0.000 claims abstract description 210
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 47
- 239000003053 toxin Substances 0.000 claims abstract description 45
- 231100000765 toxin Toxicity 0.000 claims abstract description 45
- 108700012359 toxins Proteins 0.000 claims abstract description 45
- 239000013598 vector Substances 0.000 claims abstract description 42
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 36
- 230000000694 effects Effects 0.000 claims abstract description 31
- 230000003115 biocidal effect Effects 0.000 claims abstract description 30
- 239000003242 anti bacterial agent Substances 0.000 claims abstract description 20
- 229940088710 antibiotic agent Drugs 0.000 claims abstract description 15
- 241001465754 Metazoa Species 0.000 claims abstract description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 431
- 102000004169 proteins and genes Human genes 0.000 claims description 378
- 125000003729 nucleotide group Chemical group 0.000 claims description 146
- 239000002773 nucleotide Substances 0.000 claims description 143
- 108020004414 DNA Proteins 0.000 claims description 106
- 238000000034 method Methods 0.000 claims description 97
- 239000012634 fragment Substances 0.000 claims description 96
- 239000000523 sample Substances 0.000 claims description 59
- 210000004027 cell Anatomy 0.000 claims description 51
- 241000894006 Bacteria Species 0.000 claims description 48
- 150000001413 amino acids Chemical class 0.000 claims description 41
- 230000014509 gene expression Effects 0.000 claims description 35
- 238000003786 synthesis reaction Methods 0.000 claims description 32
- 230000003321 amplification Effects 0.000 claims description 28
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 28
- 238000001514 detection method Methods 0.000 claims description 27
- 238000009396 hybridization Methods 0.000 claims description 27
- 238000000018 DNA microarray Methods 0.000 claims description 25
- 244000005700 microbiome Species 0.000 claims description 25
- 239000012472 biological sample Substances 0.000 claims description 23
- 239000013612 plasmid Substances 0.000 claims description 23
- 150000001875 compounds Chemical class 0.000 claims description 22
- 241001148062 Photorhabdus Species 0.000 claims description 21
- 238000006243 chemical reaction Methods 0.000 claims description 18
- 230000008569 process Effects 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 16
- 239000003153 chemical reaction reagent Substances 0.000 claims description 13
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 12
- 230000001105 regulatory effect Effects 0.000 claims description 12
- 241000894007 species Species 0.000 claims description 12
- 238000004458 analytical method Methods 0.000 claims description 11
- 238000010367 cloning Methods 0.000 claims description 7
- 239000002299 complementary DNA Substances 0.000 claims description 7
- 150000002894 organic compounds Chemical class 0.000 claims description 7
- 230000002285 radioactive effect Effects 0.000 claims description 7
- 230000035945 sensitivity Effects 0.000 claims description 7
- 230000000295 complement effect Effects 0.000 claims description 6
- 238000002955 isolation Methods 0.000 claims description 6
- 230000001717 pathogenic effect Effects 0.000 claims description 6
- 108020004635 Complementary DNA Proteins 0.000 claims description 5
- 239000013604 expression vector Substances 0.000 claims description 5
- 230000008105 immune reaction Effects 0.000 claims description 5
- 150000002484 inorganic compounds Chemical class 0.000 claims description 5
- 229910010272 inorganic material Inorganic materials 0.000 claims description 5
- 230000004544 DNA amplification Effects 0.000 claims description 4
- 241000282414 Homo sapiens Species 0.000 claims description 4
- 230000001939 inductive effect Effects 0.000 claims description 4
- 230000002401 inhibitory effect Effects 0.000 claims description 4
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 claims description 4
- 210000004102 animal cell Anatomy 0.000 claims description 3
- 239000008194 pharmaceutical composition Substances 0.000 claims description 3
- 238000011002 quantification Methods 0.000 claims description 3
- 206010071602 Genetic polymorphism Diseases 0.000 claims description 2
- 239000000427 antigen Substances 0.000 claims description 2
- 108091007433 antigens Proteins 0.000 claims description 2
- 102000036639 antigens Human genes 0.000 claims description 2
- 230000000853 biopesticidal effect Effects 0.000 claims description 2
- 239000013599 cloning vector Substances 0.000 claims 2
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 3
- 239000003899 bactericide agent Substances 0.000 abstract description 3
- 239000000417 fungicide Substances 0.000 abstract description 3
- 239000000575 pesticide Substances 0.000 abstract description 3
- 230000000855 fungicidal effect Effects 0.000 abstract description 2
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 101000809889 Dinoponera quadriceps M-poneratoxin-Dq4e Proteins 0.000 description 494
- 241000588724 Escherichia coli Species 0.000 description 410
- 229940023064 escherichia coli Drugs 0.000 description 405
- 235000018102 proteins Nutrition 0.000 description 372
- 101150038013 PIR gene Proteins 0.000 description 206
- 241001646716 Escherichia coli K-12 Species 0.000 description 95
- 241001646719 Escherichia coli O157:H7 Species 0.000 description 78
- 108091029795 Intergenic region Proteins 0.000 description 44
- 150000007523 nucleic acids Chemical class 0.000 description 39
- 241000588722 Escherichia Species 0.000 description 38
- 239000002243 precursor Substances 0.000 description 32
- 239000000047 product Substances 0.000 description 30
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 29
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 29
- 102000039446 nucleic acids Human genes 0.000 description 29
- 108020004707 nucleic acids Proteins 0.000 description 29
- 229940024606 amino acid Drugs 0.000 description 28
- 239000013615 primer Substances 0.000 description 28
- 102000004190 Enzymes Human genes 0.000 description 27
- 108090000790 Enzymes Proteins 0.000 description 27
- 235000001014 amino acid Nutrition 0.000 description 27
- 229940088598 enzyme Drugs 0.000 description 27
- 230000032258 transport Effects 0.000 description 27
- 230000006870 function Effects 0.000 description 25
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 24
- 239000000243 solution Substances 0.000 description 24
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 23
- 241000204362 Xylella fastidiosa Species 0.000 description 23
- 241000607626 Vibrio cholerae Species 0.000 description 22
- 229940118696 vibrio cholerae Drugs 0.000 description 22
- 229920000936 Agarose Polymers 0.000 description 21
- 230000029087 digestion Effects 0.000 description 21
- 108091000080 Phosphotransferase Proteins 0.000 description 20
- 102000020233 phosphotransferase Human genes 0.000 description 20
- 102000040430 polynucleotide Human genes 0.000 description 20
- 108091033319 polynucleotide Proteins 0.000 description 20
- 239000002157 polynucleotide Substances 0.000 description 20
- 102000003939 Membrane transport proteins Human genes 0.000 description 19
- 108090000301 Membrane transport proteins Proteins 0.000 description 19
- 108010078791 Carrier Proteins Proteins 0.000 description 18
- 102000003960 Ligases Human genes 0.000 description 18
- 108090000364 Ligases Proteins 0.000 description 18
- 239000013078 crystal Substances 0.000 description 18
- 102000014914 Carrier Proteins Human genes 0.000 description 17
- 241000607479 Yersinia pestis Species 0.000 description 17
- 230000035897 transcription Effects 0.000 description 17
- 238000013518 transcription Methods 0.000 description 17
- 241000607142 Salmonella Species 0.000 description 15
- 239000006228 supernatant Substances 0.000 description 14
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 13
- 108010007577 Exodeoxyribonuclease I Proteins 0.000 description 13
- 241000607447 Yersinia enterocolitica Species 0.000 description 13
- 239000000872 buffer Substances 0.000 description 13
- 239000013611 chromosomal DNA Substances 0.000 description 13
- 239000012528 membrane Substances 0.000 description 13
- 238000000746 purification Methods 0.000 description 13
- 101150103853 yciA gene Proteins 0.000 description 13
- 229940098232 yersinia enterocolitica Drugs 0.000 description 13
- 108010006533 ATP-Binding Cassette Transporters Proteins 0.000 description 12
- 102000005416 ATP-Binding Cassette Transporters Human genes 0.000 description 12
- 102100026004 Lactoylglutathione lyase Human genes 0.000 description 12
- 108010050765 Lactoylglutathione lyase Proteins 0.000 description 12
- 108060004795 Methyltransferase Proteins 0.000 description 12
- 230000036961 partial effect Effects 0.000 description 12
- 239000002987 primer (paints) Substances 0.000 description 12
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 11
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 11
- 102000016397 Methyltransferase Human genes 0.000 description 11
- 102000002798 Phenylalanine-tRNA Ligase Human genes 0.000 description 11
- 108010004478 Phenylalanine-tRNA Ligase Proteins 0.000 description 11
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 11
- 230000027455 binding Effects 0.000 description 11
- 239000003550 marker Substances 0.000 description 11
- 239000001632 sodium acetate Substances 0.000 description 11
- 235000017281 sodium acetate Nutrition 0.000 description 11
- 230000002103 transcriptional effect Effects 0.000 description 11
- 235000014469 Bacillus subtilis Nutrition 0.000 description 10
- 101710088194 Dehydrogenase Proteins 0.000 description 10
- 102100033452 GMP synthase [glutamine-hydrolyzing] Human genes 0.000 description 10
- 102000005720 Glutathione transferase Human genes 0.000 description 10
- 108010070675 Glutathione transferase Proteins 0.000 description 10
- 108010052285 Membrane Proteins Proteins 0.000 description 10
- 102100027330 Phosphoribosylaminoimidazole carboxylase Human genes 0.000 description 10
- 108010039725 isochorismatase Proteins 0.000 description 10
- 102000015294 isochorismatase Human genes 0.000 description 10
- 239000008188 pellet Substances 0.000 description 10
- 108091008146 restriction endonucleases Proteins 0.000 description 10
- 102100022089 Acyl-[acyl-carrier-protein] hydrolase Human genes 0.000 description 9
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 9
- 244000063299 Bacillus subtilis Species 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 9
- 108090000926 GMP synthase (glutamine-hydrolyzing) Proteins 0.000 description 9
- 108090001030 Lipoproteins Proteins 0.000 description 9
- 102000004895 Lipoproteins Human genes 0.000 description 9
- 108091034117 Oligonucleotide Proteins 0.000 description 9
- 108700026244 Open Reading Frames Proteins 0.000 description 9
- 229910019142 PO4 Inorganic materials 0.000 description 9
- 102000001618 Threonine-tRNA Ligase Human genes 0.000 description 9
- 108010029287 Threonine-tRNA ligase Proteins 0.000 description 9
- 241000204366 Xylella Species 0.000 description 9
- 238000000605 extraction Methods 0.000 description 9
- 230000004048 modification Effects 0.000 description 9
- 238000012986 modification Methods 0.000 description 9
- 230000035772 mutation Effects 0.000 description 9
- -1 ohgonucleotide Proteins 0.000 description 9
- 239000010452 phosphate Substances 0.000 description 9
- 238000001556 precipitation Methods 0.000 description 9
- 230000028327 secretion Effects 0.000 description 9
- 241001515965 unidentified phage Species 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 108030006765 Formyltetrahydrofolate deformylases Proteins 0.000 description 8
- 241000948192 Hamiltonella virus APSE1 Species 0.000 description 8
- 102000018697 Membrane Proteins Human genes 0.000 description 8
- 241000588770 Proteus mirabilis Species 0.000 description 8
- 108010086211 Riboflavin synthase Proteins 0.000 description 8
- 108010056371 Succinyl-diaminopimelate desuccinylase Proteins 0.000 description 8
- 241000204666 Thermotoga maritima Species 0.000 description 8
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 8
- 108010052305 exodeoxyribonuclease III Proteins 0.000 description 8
- 239000000499 gel Substances 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 230000004060 metabolic process Effects 0.000 description 8
- 230000010076 replication Effects 0.000 description 8
- 238000012163 sequencing technique Methods 0.000 description 8
- 239000011734 sodium Substances 0.000 description 8
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 7
- 108010001539 D-lactate dehydrogenase Proteins 0.000 description 7
- 102000007528 DNA Polymerase III Human genes 0.000 description 7
- 108010071146 DNA Polymerase III Proteins 0.000 description 7
- 108090000323 DNA Topoisomerases Proteins 0.000 description 7
- 102000003915 DNA Topoisomerases Human genes 0.000 description 7
- 102100023319 Dihydrolipoyl dehydrogenase, mitochondrial Human genes 0.000 description 7
- 101000600843 Escherichia coli (strain K12) Probable endopeptidase NlpC Proteins 0.000 description 7
- PSJQCAMBOYBQEU-UHFFFAOYSA-N Glyoxalase I Natural products CC=CC(=O)OCC1=CC(O)C(O)C(O)C1=O PSJQCAMBOYBQEU-UHFFFAOYSA-N 0.000 description 7
- 241000203407 Methanocaldococcus jannaschii Species 0.000 description 7
- 102000004316 Oxidoreductases Human genes 0.000 description 7
- 108090000854 Oxidoreductases Proteins 0.000 description 7
- 108090000434 Phosphoribosylaminoimidazolesuccinocarboxamide synthases Proteins 0.000 description 7
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 7
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 7
- 108010020764 Transposases Proteins 0.000 description 7
- 102000008579 Transposases Human genes 0.000 description 7
- 230000001419 dependent effect Effects 0.000 description 7
- 230000008021 deposition Effects 0.000 description 7
- 108020000161 polyphosphate kinase Proteins 0.000 description 7
- 230000014616 translation Effects 0.000 description 7
- 238000013519 translation Methods 0.000 description 7
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 6
- 102000021527 ATP binding proteins Human genes 0.000 description 6
- 108091011108 ATP binding proteins Proteins 0.000 description 6
- 102000053602 DNA Human genes 0.000 description 6
- 241000588700 Dickeya chrysanthemi Species 0.000 description 6
- 241000702204 Haemophilus virus HP1 Species 0.000 description 6
- 241000238631 Hexapoda Species 0.000 description 6
- 108010075869 Isocitrate Dehydrogenase Proteins 0.000 description 6
- 102000012011 Isocitrate Dehydrogenase Human genes 0.000 description 6
- 241000588915 Klebsiella aerogenes Species 0.000 description 6
- 102100032618 N-acetylglutamate synthase, mitochondrial Human genes 0.000 description 6
- 108010038807 Oligopeptides Proteins 0.000 description 6
- 102000015636 Oligopeptides Human genes 0.000 description 6
- 241000187432 Streptomyces coelicolor Species 0.000 description 6
- 101710166729 Tail fiber protein Proteins 0.000 description 6
- 101710172405 Thiol peroxidase Proteins 0.000 description 6
- 241000607734 Yersinia <bacteria> Species 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000011543 agarose gel Substances 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- 210000004708 ribosome subunit Anatomy 0.000 description 6
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 6
- 238000006467 substitution reaction Methods 0.000 description 6
- 108091000044 4-hydroxy-tetrahydrodipicolinate synthase Proteins 0.000 description 5
- 108010032178 Amino-acid N-acetyltransferase Proteins 0.000 description 5
- 102100023376 Corrinoid adenosyltransferase Human genes 0.000 description 5
- 108030001666 Corrinoid adenosyltransferases Proteins 0.000 description 5
- 108010003989 D-amino-acid oxidase Proteins 0.000 description 5
- 102000004674 D-amino-acid oxidase Human genes 0.000 description 5
- 108010077448 Diamine N-acetyltransferase Proteins 0.000 description 5
- 108700034291 EC 2.7.1.69 Proteins 0.000 description 5
- 108060002716 Exonuclease Proteins 0.000 description 5
- 102100029075 Exonuclease 1 Human genes 0.000 description 5
- 241000233866 Fungi Species 0.000 description 5
- 241001235200 Haemophilus influenzae Rd KW20 Species 0.000 description 5
- 102000004157 Hydrolases Human genes 0.000 description 5
- 108090000604 Hydrolases Proteins 0.000 description 5
- 102100037845 Isocitrate dehydrogenase [NADP], mitochondrial Human genes 0.000 description 5
- 108010086428 NADH Dehydrogenase Proteins 0.000 description 5
- 102000006746 NADH Dehydrogenase Human genes 0.000 description 5
- 241000606860 Pasteurella Species 0.000 description 5
- 102000035195 Peptidases Human genes 0.000 description 5
- 108091005804 Peptidases Proteins 0.000 description 5
- 241000589516 Pseudomonas Species 0.000 description 5
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
- 108020004566 Transfer RNA Proteins 0.000 description 5
- 108700023183 UTP-glucose-1-phosphate uridylyltransferases Proteins 0.000 description 5
- 101000649206 Xanthomonas campestris pv. campestris (strain 8004) Uridine 5'-monophosphate transferase Proteins 0.000 description 5
- 102000013165 exonuclease Human genes 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 101150080758 tonB gene Proteins 0.000 description 5
- 102100025573 1-alkyl-2-acetylglycerophosphocholine esterase Human genes 0.000 description 4
- GLDQAMYCGOIJDV-UHFFFAOYSA-N 2,3-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(O)=C1O GLDQAMYCGOIJDV-UHFFFAOYSA-N 0.000 description 4
- 108030003562 3-oxoacyl-[acyl-carrier-protein] reductases Proteins 0.000 description 4
- 108050003185 3-oxoacyl-[acyl-carrier-protein] synthase 2 Proteins 0.000 description 4
- 102100040768 60S ribosomal protein L32 Human genes 0.000 description 4
- 101710146995 Acyl carrier protein Proteins 0.000 description 4
- 108010024976 Asparaginase Proteins 0.000 description 4
- 108010049152 Cold Shock Proteins and Peptides Proteins 0.000 description 4
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 4
- 108010061075 Enterobactin Proteins 0.000 description 4
- 101000874239 Escherichia coli (strain K12) L-serine dehydratase 1 Proteins 0.000 description 4
- 241000124092 Escherichia virus N15 Species 0.000 description 4
- 241000606768 Haemophilus influenzae Species 0.000 description 4
- 241000588650 Neisseria meningitidis Species 0.000 description 4
- 101710195435 Periplasmic oligopeptide-binding protein Proteins 0.000 description 4
- 101710199920 Phage shock protein B Proteins 0.000 description 4
- 101710108782 Proton/sodium-glutamate symport protein Proteins 0.000 description 4
- 102100034407 Pyridoxine-5'-phosphate oxidase Human genes 0.000 description 4
- 101710181816 Pyruvate-formate-lyase deactivase Proteins 0.000 description 4
- 101710197208 Regulatory protein cro Proteins 0.000 description 4
- 101710186773 Selenide, water dikinase Proteins 0.000 description 4
- 241000192581 Synechocystis sp. Species 0.000 description 4
- 241000607598 Vibrio Species 0.000 description 4
- 102000005421 acetyltransferase Human genes 0.000 description 4
- 108020002494 acetyltransferase Proteins 0.000 description 4
- 239000008346 aqueous phase Substances 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 238000010168 coupling process Methods 0.000 description 4
- 238000005859 coupling reaction Methods 0.000 description 4
- 238000012217 deletion Methods 0.000 description 4
- 230000037430 deletion Effects 0.000 description 4
- 235000011180 diphosphates Nutrition 0.000 description 4
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 4
- 238000004520 electroporation Methods 0.000 description 4
- SERBHKJMVBATSJ-BZSNNMDCSA-N enterobactin Chemical compound OC1=CC=CC(C(=O)N[C@@H]2C(OC[C@@H](C(=O)OC[C@@H](C(=O)OC2)NC(=O)C=2C(=C(O)C=CC=2)O)NC(=O)C=2C(=C(O)C=CC=2)O)=O)=C1O SERBHKJMVBATSJ-BZSNNMDCSA-N 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 4
- 108010079502 exoribonuclease T Proteins 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- UPWPDUACHOATKO-UHFFFAOYSA-K gallium trichloride Chemical compound Cl[Ga](Cl)Cl UPWPDUACHOATKO-UHFFFAOYSA-K 0.000 description 4
- 230000000749 insecticidal effect Effects 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 230000035800 maturation Effects 0.000 description 4
- 108020004999 messenger RNA Proteins 0.000 description 4
- 239000011325 microbead Substances 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 108010092223 phosphoenolpyruvate-mannose phosphotransferase Proteins 0.000 description 4
- 108010035774 phosphoribosylaminoimidazole carboxylase Proteins 0.000 description 4
- 108010017378 prolyl aminopeptidase Proteins 0.000 description 4
- 235000019833 protease Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 102000052866 Amino Acyl-tRNA Synthetases Human genes 0.000 description 3
- 108700028939 Amino Acyl-tRNA Synthetases Proteins 0.000 description 3
- 108090000084 Antiporters Proteins 0.000 description 3
- 102000003669 Antiporters Human genes 0.000 description 3
- 108010070255 Aspartate-ammonia ligase Proteins 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 101001074429 Bacillus subtilis (strain 168) Polyketide biosynthesis acyltransferase homolog PksD Proteins 0.000 description 3
- 101100376109 Bacillus subtilis (strain 168) yeeF gene Proteins 0.000 description 3
- 101100433083 Bacillus subtilis (strain 168) yydG gene Proteins 0.000 description 3
- 101000936617 Bacillus velezensis (strain DSM 23117 / BGSC 10A6 / FZB42) Polyketide biosynthesis acyltransferase homolog BaeD Proteins 0.000 description 3
- 102100034560 Cytosol aminopeptidase Human genes 0.000 description 3
- 108090000579 DNA topoisomerase III Proteins 0.000 description 3
- 241000192091 Deinococcus radiodurans Species 0.000 description 3
- 102100034274 Diamine acetyltransferase 1 Human genes 0.000 description 3
- 108700035791 EC 6.3.5.4 Proteins 0.000 description 3
- 102100031780 Endonuclease Human genes 0.000 description 3
- 108010042407 Endonucleases Proteins 0.000 description 3
- 101100464246 Escherichia coli (strain K12) plaP gene Proteins 0.000 description 3
- 108010077487 Ethanolamine ammonia-lyase Proteins 0.000 description 3
- 108010046914 Exodeoxyribonuclease V Proteins 0.000 description 3
- 102100029908 Exonuclease 3'-5' domain-containing protein 2 Human genes 0.000 description 3
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 3
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 3
- 101710137787 Glyceraldehyde-3-phosphate dehydrogenase A Proteins 0.000 description 3
- 241000606790 Haemophilus Species 0.000 description 3
- 108010072462 Hydroxymethyl and Formyl Transferases Proteins 0.000 description 3
- 102000006933 Hydroxymethyl and Formyl Transferases Human genes 0.000 description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 3
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 3
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
- 102100027329 Malonyl-CoA-acyl carrier protein transacylase, mitochondrial Human genes 0.000 description 3
- 108700040177 Nicotinate-nucleotide-dimethylbenzimidazole phosphoribosyltransferases Proteins 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 241000588912 Pantoea agglomerans Species 0.000 description 3
- 241000588702 Pectobacterium carotovorum subsp. carotovorum Species 0.000 description 3
- 101710085931 Peroxiredoxin Bcp Proteins 0.000 description 3
- 102100032420 Protein S100-A9 Human genes 0.000 description 3
- 241000589623 Pseudomonas syringae pv. syringae Species 0.000 description 3
- 101710176422 Putative peroxiredoxin bcp Proteins 0.000 description 3
- 101710193192 Putative transcriptional regulator Proteins 0.000 description 3
- 108010028039 Pyridoxaminephosphate Oxidase Proteins 0.000 description 3
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 3
- 102000017528 Ribosomal protein L35 Human genes 0.000 description 3
- 108050005789 Ribosomal protein L35 Proteins 0.000 description 3
- 101710162325 Ribosomal small subunit pseudouridine synthase A Proteins 0.000 description 3
- 241000607715 Serratia marcescens Species 0.000 description 3
- 108090000088 Symporters Proteins 0.000 description 3
- 102000003673 Symporters Human genes 0.000 description 3
- ZQVJBRJGDVZANE-UHFFFAOYSA-N Syringomycin Natural products N1C(=O)C(CCCN=C(N)N)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CO)NC(=O)C(NC(=O)CC(O)CCCCCCCCC)COC(=O)C(C(O)CCl)NC(=O)C(C(O)C(O)=O)NC(=O)C(=CC)NC(=O)C1CC1=CC=CC=C1 ZQVJBRJGDVZANE-UHFFFAOYSA-N 0.000 description 3
- 102100024855 Three-prime repair exonuclease 1 Human genes 0.000 description 3
- 102100037357 Thymidylate kinase Human genes 0.000 description 3
- 102000040945 Transcription factor Human genes 0.000 description 3
- 108091023040 Transcription factor Proteins 0.000 description 3
- 101800000385 Transmembrane protein Proteins 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 102100038834 UTP-glucose-1-phosphate uridylyltransferase Human genes 0.000 description 3
- 102000048175 UTP-glucose-1-phosphate uridylyltransferases Human genes 0.000 description 3
- 108030000857 [Acyl-carrier-protein] S-malonyltransferases Proteins 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 125000000539 amino acid group Chemical group 0.000 description 3
- 108091008324 binding proteins Proteins 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 230000008878 coupling Effects 0.000 description 3
- 108010000742 dTMP kinase Proteins 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 229940071221 dihydroxybenzoate Drugs 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000037149 energy metabolism Effects 0.000 description 3
- 229940092559 enterobacter aerogenes Drugs 0.000 description 3
- 230000006862 enzymatic digestion Effects 0.000 description 3
- 108010021469 exodeoxyribonuclease VII Proteins 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 102000034356 gene-regulatory proteins Human genes 0.000 description 3
- 108091006104 gene-regulatory proteins Proteins 0.000 description 3
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 3
- 229940047650 haemophilus influenzae Drugs 0.000 description 3
- 229940025294 hemin Drugs 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 108010029918 isocitrate dehydrogenase (NADP+) Proteins 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 108010057757 methionyl-tRNA formyltransferase Proteins 0.000 description 3
- 101150000399 nhaB gene Proteins 0.000 description 3
- 239000002777 nucleoside Substances 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 108010050430 phosphoglycolate phosphatase Proteins 0.000 description 3
- 150000003904 phospholipids Chemical class 0.000 description 3
- 229920002401 polyacrylamide Polymers 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 101150008241 purT gene Proteins 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- BBIKPGRUAMIMIA-UHFFFAOYSA-N sapb Chemical compound C1SCC(C(=O)NC(CC(N)=O)C(O)=O)NC(=O)C(C(C)O)NC(=O)C(C(C)O)NC(=O)C(C(C)CC)NC(=O)C(=C)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C1NC(=O)C(CC(O)=O)NC(=O)CNC(=O)C1NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(C)NC(=O)C(CCCNC(N)=N)NC(=O)C(NC(=O)CNC(=O)C(N)C(C)O)CSC1 BBIKPGRUAMIMIA-UHFFFAOYSA-N 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 229940063673 spermidine Drugs 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 108010078552 syringomycin Proteins 0.000 description 3
- 108010036169 three prime repair exonuclease 1 Proteins 0.000 description 3
- 108091000036 uracil phosphoribosyltransferase Proteins 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 101150070650 yceD gene Proteins 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- WKZGKZQVLRQTCT-ABLWVSNPSA-N (2S)-2-[[4-[(2-amino-4-oxo-5,6,7,8-tetrahydro-3H-pteridin-6-yl)methylamino]benzoyl]amino]-5-formyloxy-5-oxopentanoic acid Chemical compound N1C=2C(=O)NC(N)=NC=2NCC1CNC1=CC=C(C(=O)N[C@@H](CCC(=O)OC=O)C(O)=O)C=C1 WKZGKZQVLRQTCT-ABLWVSNPSA-N 0.000 description 2
- SRZXCOWFGPICGA-UHFFFAOYSA-N 1,6-Hexanedithiol Chemical compound SCCCCCCS SRZXCOWFGPICGA-UHFFFAOYSA-N 0.000 description 2
- UWOCFOFVIBZJGH-UHFFFAOYSA-N 2,3-dihydrodipicolinic acid Chemical compound OC(=O)C1CC=CC(C(O)=O)=N1 UWOCFOFVIBZJGH-UHFFFAOYSA-N 0.000 description 2
- 101710161460 3-oxoacyl-[acyl-carrier-protein] synthase Proteins 0.000 description 2
- QYOJSKGCWNAKGW-PBXRRBTRSA-K 3-phosphonatoshikimate(3-) Chemical compound O[C@@H]1CC(C([O-])=O)=C[C@@H](OP([O-])([O-])=O)[C@H]1O QYOJSKGCWNAKGW-PBXRRBTRSA-K 0.000 description 2
- 108010020183 3-phosphoshikimate 1-carboxyvinyltransferase Proteins 0.000 description 2
- LJUQGASMPRMWIW-UHFFFAOYSA-N 5,6-dimethylbenzimidazole Chemical compound C1=C(C)C(C)=CC2=C1NC=N2 LJUQGASMPRMWIW-UHFFFAOYSA-N 0.000 description 2
- QUTYKIXIUDQOLK-PRJMDXOYSA-N 5-O-(1-carboxyvinyl)-3-phosphoshikimic acid Chemical compound O[C@H]1[C@H](OC(=C)C(O)=O)CC(C(O)=O)=C[C@H]1OP(O)(O)=O QUTYKIXIUDQOLK-PRJMDXOYSA-N 0.000 description 2
- 101710135916 50S ribosomal protein L32 Proteins 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 108091006112 ATPases Proteins 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 108050006855 Acriflavin resistance proteins Proteins 0.000 description 2
- 108010058912 Acyl-Carrier Protein S-Malonyltransferase Proteins 0.000 description 2
- 102000006488 Acyl-Carrier Protein S-Malonyltransferase Human genes 0.000 description 2
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 2
- 102000004092 Amidohydrolases Human genes 0.000 description 2
- 108090000531 Amidohydrolases Proteins 0.000 description 2
- 241000192531 Anabaena sp. Species 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
- 102100023927 Asparagine synthetase [glutamine-hydrolyzing] Human genes 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 101000666833 Autographa californica nuclear polyhedrosis virus Uncharacterized 20.8 kDa protein in FGF-VUBI intergenic region Proteins 0.000 description 2
- 101000977027 Azospirillum brasilense Uncharacterized protein in nodG 5'region Proteins 0.000 description 2
- 241000006382 Bacillus halodurans Species 0.000 description 2
- 101000929885 Bacillus subtilis (strain 168) Isochorismatase Proteins 0.000 description 2
- 101100228546 Bacillus subtilis (strain 168) folE2 gene Proteins 0.000 description 2
- 101000962005 Bacillus thuringiensis Uncharacterized 23.6 kDa protein Proteins 0.000 description 2
- 241000589875 Campylobacter jejuni Species 0.000 description 2
- 241001647367 Chlamydia muridarum Species 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 238000007400 DNA extraction Methods 0.000 description 2
- 230000004543 DNA replication Effects 0.000 description 2
- 101710116895 DNA-binding protein H-NS Proteins 0.000 description 2
- 101710150441 DNA-invertase Proteins 0.000 description 2
- 102100037840 Dehydrogenase/reductase SDR family member 2, mitochondrial Human genes 0.000 description 2
- 102000016911 Deoxyribonucleases Human genes 0.000 description 2
- 108010053770 Deoxyribonucleases Proteins 0.000 description 2
- 101000785191 Drosophila melanogaster Uncharacterized 50 kDa protein in type I retrotransposable element R1DM Proteins 0.000 description 2
- 108700033381 EC 1.1.1.42 Proteins 0.000 description 2
- 108700035164 EC 4.2.1.13 Proteins 0.000 description 2
- 108700035100 EC 4.2.1.52 Proteins 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 101710198510 Enoyl-[acyl-carrier-protein] reductase [NADH] Proteins 0.000 description 2
- 101000747704 Enterobacteria phage N4 Uncharacterized protein Gp1 Proteins 0.000 description 2
- 101000877444 Enterobacteria phage T4 Recombination endonuclease VII Proteins 0.000 description 2
- SERBHKJMVBATSJ-UHFFFAOYSA-N Enterobactin Natural products OC1=CC=CC(C(=O)NC2C(OCC(C(=O)OCC(C(=O)OC2)NC(=O)C=2C(=C(O)C=CC=2)O)NC(=O)C=2C(=C(O)C=CC=2)O)=O)=C1O SERBHKJMVBATSJ-UHFFFAOYSA-N 0.000 description 2
- 101000861206 Enterococcus faecalis (strain ATCC 700802 / V583) Uncharacterized protein EF_A0048 Proteins 0.000 description 2
- 241000588698 Erwinia Species 0.000 description 2
- 241000588694 Erwinia amylovora Species 0.000 description 2
- 101001092694 Escherichia coli (strain K12) RecBCD enzyme subunit RecD Proteins 0.000 description 2
- 101100309542 Escherichia coli (strain K12) sbcD gene Proteins 0.000 description 2
- 101000957774 Escherichia coli Mannose-1-phosphate guanylyltransferase Proteins 0.000 description 2
- 101000957775 Escherichia coli Mannose-1-phosphate guanylyltransferase Proteins 0.000 description 2
- 241000010756 Escherichia coli O157:H7 str. EDL933 Species 0.000 description 2
- 101000769180 Escherichia coli Uncharacterized 11.1 kDa protein Proteins 0.000 description 2
- 241001302160 Escherichia coli str. K-12 substr. DH10B Species 0.000 description 2
- 101000653753 Escherichia phage Mu Tail fiber protein S Proteins 0.000 description 2
- 241000702055 Escherichia virus HK022 Species 0.000 description 2
- 241000702189 Escherichia virus Mu Species 0.000 description 2
- 101710185850 Exodeoxyribonuclease Proteins 0.000 description 2
- 102000019236 Exonuclease V Human genes 0.000 description 2
- 108010067157 Ferrichrome Proteins 0.000 description 2
- 102000008857 Ferritin Human genes 0.000 description 2
- 108050000784 Ferritin Proteins 0.000 description 2
- 238000008416 Ferritin Methods 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 101710197017 Formyltetrahydrofolate deformylase Proteins 0.000 description 2
- FFFHZYDWPBMWHY-UHFFFAOYSA-N HOMOCYSTEINE Chemical compound OC(=O)C(N)CCS FFFHZYDWPBMWHY-UHFFFAOYSA-N 0.000 description 2
- 101710168840 Hemin receptor Proteins 0.000 description 2
- 108010006464 Hemolysin Proteins Proteins 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- 108010015268 Integration Host Factors Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- 101710148772 L-serine dehydratase 1 Proteins 0.000 description 2
- 241000724748 Lactobacillus phage phiadh Species 0.000 description 2
- 241000589242 Legionella pneumophila Species 0.000 description 2
- 101000976301 Leptospira interrogans Uncharacterized 35 kDa protein in sph 3'region Proteins 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 101710185515 Major outer membrane lipoprotein Lpp Proteins 0.000 description 2
- 108050003365 Malonyl CoA-acyl carrier protein transacylases Proteins 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 101710105874 Membrane-bound lytic murein transglycosylase E Proteins 0.000 description 2
- 241000203353 Methanococcus Species 0.000 description 2
- 102100031551 Methionine synthase Human genes 0.000 description 2
- 101000658690 Neisseria meningitidis serogroup B Transposase for insertion sequence element IS1106 Proteins 0.000 description 2
- 241000244206 Nematoda Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
- 101710169513 Oligopeptide transport system permease protein OppC Proteins 0.000 description 2
- 101710116435 Outer membrane protein Proteins 0.000 description 2
- 101710101200 PTS system mannose-specific EIID component Proteins 0.000 description 2
- 108010090127 Periplasmic Proteins Proteins 0.000 description 2
- 241000701980 Phage 434 Species 0.000 description 2
- 108010064209 Phosphoribosylglycinamide formyltransferase Proteins 0.000 description 2
- 101001135788 Pinus taeda (+)-alpha-pinene synthase, chloroplastic Proteins 0.000 description 2
- 101710143707 Precorrin-8X methylmutase Proteins 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 101001045444 Proteus vulgaris Endoribonuclease HigB Proteins 0.000 description 2
- 241000701550 Pseudoalteromonas virus PM2 Species 0.000 description 2
- 101001100822 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) Pyocin-S2 Proteins 0.000 description 2
- 101001100831 Pseudomonas aeruginosa Pyocin-S1 Proteins 0.000 description 2
- 241000589776 Pseudomonas putida Species 0.000 description 2
- 101000748660 Pseudomonas savastanoi Uncharacterized 21 kDa protein in iaaL 5'region Proteins 0.000 description 2
- 229930185560 Pseudouridine Natural products 0.000 description 2
- PTJWIQPHWPFNBW-UHFFFAOYSA-N Pseudouridine C Natural products OC1C(O)C(CO)OC1C1=CNC(=O)NC1=O PTJWIQPHWPFNBW-UHFFFAOYSA-N 0.000 description 2
- RADKZDMFGJYCBB-UHFFFAOYSA-N Pyridoxal Chemical compound CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 2
- 101710088936 Pyruvate kinase I Proteins 0.000 description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
- 101710155259 Repressor protein CI Proteins 0.000 description 2
- 241000589187 Rhizobium sp. Species 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 102000002278 Ribosomal Proteins Human genes 0.000 description 2
- 108010000605 Ribosomal Proteins Proteins 0.000 description 2
- 101000584469 Rice tungro bacilliform virus (isolate Philippines) Protein P1 Proteins 0.000 description 2
- 241000606697 Rickettsia prowazekii Species 0.000 description 2
- 101000845103 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Sorbitol dehydrogenase 1 Proteins 0.000 description 2
- 241000235347 Schizosaccharomyces pombe Species 0.000 description 2
- 102000030594 Selenophosphate synthetase Human genes 0.000 description 2
- 108010016233 Selenophosphate synthetase Proteins 0.000 description 2
- 241000607720 Serratia Species 0.000 description 2
- 108020004682 Single-Stranded DNA Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 101000818096 Spirochaeta aurantia Uncharacterized 15.5 kDa protein in trpE 3'region Proteins 0.000 description 2
- 241000193998 Streptococcus pneumoniae Species 0.000 description 2
- 241000187747 Streptomyces Species 0.000 description 2
- 101000766081 Streptomyces ambofaciens Uncharacterized HTH-type transcriptional regulator in unstable DNA locus Proteins 0.000 description 2
- 102000005262 Sulfatase Human genes 0.000 description 2
- 101000804403 Synechococcus elongatus (strain PCC 7942 / FACHB-805) Uncharacterized HIT-like protein Synpcc7942_1390 Proteins 0.000 description 2
- 101000750910 Synechococcus elongatus (strain PCC 7942 / FACHB-805) Uncharacterized HTH-type transcriptional regulator Synpcc7942_2319 Proteins 0.000 description 2
- 101000644897 Synechococcus sp. (strain ATCC 27264 / PCC 7002 / PR-6) Uncharacterized protein SYNPCC7002_B0001 Proteins 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 101710157588 Transcription-repair-coupling factor Proteins 0.000 description 2
- 101710093706 Tryptophan permease Proteins 0.000 description 2
- 101710124173 Tryptophan-specific transport protein Proteins 0.000 description 2
- 101710117021 Tyrosine-protein phosphatase YopH Proteins 0.000 description 2
- HSCJRCZFDFQWRP-JZMIEXBBSA-N UDP-alpha-D-glucose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-JZMIEXBBSA-N 0.000 description 2
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- 101000916336 Xenopus laevis Transposon TX1 uncharacterized 82 kDa protein Proteins 0.000 description 2
- 101100284779 Yersinia enterocolitica hemP gene Proteins 0.000 description 2
- 101100284781 Yersinia enterocolitica hemS gene Proteins 0.000 description 2
- 208000025087 Yersinia pseudotuberculosis infectious disease Diseases 0.000 description 2
- 101001000760 Zea mays Putative Pol polyprotein from transposon element Bs1 Proteins 0.000 description 2
- 101000678262 Zymomonas mobilis subsp. mobilis (strain ATCC 10988 / DSM 424 / LMG 404 / NCIMB 8938 / NRRL B-806 / ZM1) 65 kDa protein Proteins 0.000 description 2
- 241000606834 [Haemophilus] ducreyi Species 0.000 description 2
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 229960003767 alanine Drugs 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 229960003272 asparaginase Drugs 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-M asparaginate Chemical compound [O-]C(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-M 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 108010027375 bacterioferritin Proteins 0.000 description 2
- RNBGYGVWRKECFJ-ARQDHWQXSA-N beta-D-fructofuranose 1,6-bisphosphate Chemical compound O[C@H]1[C@H](O)[C@@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O RNBGYGVWRKECFJ-ARQDHWQXSA-N 0.000 description 2
- 108010047754 beta-Glucosidase Proteins 0.000 description 2
- WGDUUQDYDIIBKT-UHFFFAOYSA-N beta-Pseudouridine Natural products OC1OC(CN2C=CC(=O)NC2=O)C(O)C1O WGDUUQDYDIIBKT-UHFFFAOYSA-N 0.000 description 2
- 238000006065 biodegradation reaction Methods 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 229920001222 biopolymer Polymers 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- ASARMUCNOOHMLO-WLORSUFZSA-L cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2s)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O ASARMUCNOOHMLO-WLORSUFZSA-L 0.000 description 2
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 2
- FEZWOUWWJOYMLT-DSRCUDDDSA-M cobalt;[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,1 Chemical compound [Co].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FEZWOUWWJOYMLT-DSRCUDDDSA-M 0.000 description 2
- 108010028667 cobyric acid synthase Proteins 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 102000003630 enoyl-CoA hydratase/isomerase Human genes 0.000 description 2
- 230000000967 entomopathogenic effect Effects 0.000 description 2
- 238000011066 ex-situ storage Methods 0.000 description 2
- 101150080665 exbB gene Proteins 0.000 description 2
- GGUNGDGGXMHBMJ-UHFFFAOYSA-N ferrichrome Chemical compound [Fe+3].CC(=O)N([O-])CCCC1NC(=O)CNC(=O)CNC(=O)CNC(=O)C(CCCN([O-])C(C)=O)NC(=O)C(CCCN([O-])C(C)=O)NC1=O GGUNGDGGXMHBMJ-UHFFFAOYSA-N 0.000 description 2
- 238000012268 genome sequencing Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- BTIJJDXEELBZFS-UHFFFAOYSA-K hemin Chemical compound [Cl-].[Fe+3].[N-]1C(C=C2C(=C(C)C(C=C3C(=C(C)C(=C4)[N-]3)C=C)=N2)C=C)=C(C)C(CCC(O)=O)=C1C=C1C(CCC(O)=O)=C(C)C4=N1 BTIJJDXEELBZFS-UHFFFAOYSA-K 0.000 description 2
- 239000003228 hemolysin Substances 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000002917 insecticide Substances 0.000 description 2
- ODBLHEXUDAPZAU-UHFFFAOYSA-N isocitric acid Chemical compound OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 2
- 229940115932 legionella pneumophila Drugs 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 238000013508 migration Methods 0.000 description 2
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 2
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 125000003835 nucleoside group Chemical group 0.000 description 2
- 239000002751 oligonucleotide probe Substances 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 108010082406 peptide permease Proteins 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 230000026017 phage shock Effects 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 210000001236 prokaryotic cell Anatomy 0.000 description 2
- 229960002429 proline Drugs 0.000 description 2
- PTJWIQPHWPFNBW-GBNDHIKLSA-N pseudouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1C1=CNC(=O)NC1=O PTJWIQPHWPFNBW-GBNDHIKLSA-N 0.000 description 2
- 108091023023 pteridine reductase Proteins 0.000 description 2
- 150000003212 purines Chemical class 0.000 description 2
- 108010025281 pyoverdin Proteins 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 150000003230 pyrimidines Chemical class 0.000 description 2
- 101150007176 qacE gene Proteins 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 230000006798 recombination Effects 0.000 description 2
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 2
- 230000009711 regulatory function Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 108010025325 ribosomal protein L32 Proteins 0.000 description 2
- 229940046939 rickettsia prowazekii Drugs 0.000 description 2
- 108020000318 saccharopine dehydrogenase Proteins 0.000 description 2
- 101150111893 sapB gene Proteins 0.000 description 2
- 101150011745 sapF gene Proteins 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000010187 selection method Methods 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 108010089727 siderophore receptors Proteins 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 2
- 108060007951 sulfatase Proteins 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 230000014621 translational initiation Effects 0.000 description 2
- 101150047903 vapA gene Proteins 0.000 description 2
- 101150018867 yeiE gene Proteins 0.000 description 2
- GHPDWAAGDJPBLL-ZVGUSBNCSA-N (2r,3r)-2,3-dihydroxybutanedioic acid;hydrazine Chemical compound NN.OC(=O)[C@H](O)[C@@H](O)C(O)=O GHPDWAAGDJPBLL-ZVGUSBNCSA-N 0.000 description 1
- ZQVJBRJGDVZANE-MXDMHAPNSA-N (2s)-2-[(3s,6s,9z,12s,15s,18s,21r,24r,27s)-18,21-bis(2-aminoethyl)-12-benzyl-3-[(1s)-2-chloro-1-hydroxyethyl]-15-[3-(diaminomethylideneamino)propyl]-9-ethylidene-27-[[(3s)-3-hydroxydodecanoyl]amino]-24-(hydroxymethyl)-2,5,8,11,14,17,20,23,26-nonaoxo-1-oxa Chemical compound N1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCN)NC(=O)[C@@H](CCN)NC(=O)[C@@H](CO)NC(=O)[C@@H](NC(=O)C[C@@H](O)CCCCCCCCC)COC(=O)[C@H]([C@H](O)CCl)NC(=O)[C@H]([C@H](O)C(O)=O)NC(=O)\C(=C\C)NC(=O)[C@@H]1CC1=CC=CC=C1 ZQVJBRJGDVZANE-MXDMHAPNSA-N 0.000 description 1
- LXJXRIRHZLFYRP-VKHMYHEASA-L (R)-2-Hydroxy-3-(phosphonooxy)-propanal Natural products O=C[C@H](O)COP([O-])([O-])=O LXJXRIRHZLFYRP-VKHMYHEASA-L 0.000 description 1
- DEIBXAPEZDJDRC-UHFFFAOYSA-M (dimethylaminomethylideneamino)methylidene-dimethylazanium;chloride Chemical compound [Cl-].CN(C)C=NC=[N+](C)C DEIBXAPEZDJDRC-UHFFFAOYSA-M 0.000 description 1
- RRVPPYNAZJRZFR-VYOBOKEXSA-N 1-oleoyl-2-palmitoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCC\C=C/CCCCCCCC RRVPPYNAZJRZFR-VYOBOKEXSA-N 0.000 description 1
- VBNGJYNPUFWTKX-UHFFFAOYSA-N 10,10-diamino-1,6-dioxacyclotridecane-2,5,7,13-tetrone Chemical compound NC1(CCC(=O)OC(CCC(=O)OC(CC1)=O)=O)N VBNGJYNPUFWTKX-UHFFFAOYSA-N 0.000 description 1
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- GLDQAMYCGOIJDV-UHFFFAOYSA-M 2,3-dihydroxybenzoate Chemical compound OC1=CC=CC(C([O-])=O)=C1O GLDQAMYCGOIJDV-UHFFFAOYSA-M 0.000 description 1
- CNTRQUPPKZMKSS-UHFFFAOYSA-N 2-(hydroxymethylamino)-7,8-dihydro-1h-pteridin-4-one Chemical compound N1CC=NC2=C1N=C(NCO)NC2=O CNTRQUPPKZMKSS-UHFFFAOYSA-N 0.000 description 1
- 108090000168 2-Oxoisovalerate Dehydrogenase (Acylating) Proteins 0.000 description 1
- KPGXRSRHYNQIFN-UHFFFAOYSA-L 2-oxoglutarate(2-) Chemical compound [O-]C(=O)CCC(=O)C([O-])=O KPGXRSRHYNQIFN-UHFFFAOYSA-L 0.000 description 1
- 102100035352 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial Human genes 0.000 description 1
- ASCFNMCAHFUBCO-UHFFFAOYSA-N 2-phosphoglycolic acid Chemical compound OC(=O)COP(O)(O)=O ASCFNMCAHFUBCO-UHFFFAOYSA-N 0.000 description 1
- NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
- UKEFGIFPIOLTSL-UHFFFAOYSA-N 3-(methylsulfinylmethyl)pyridine Chemical compound CS(=O)CC1=CC=CN=C1 UKEFGIFPIOLTSL-UHFFFAOYSA-N 0.000 description 1
- 108010046716 3-Methyl-2-Oxobutanoate Dehydrogenase (Lipoamide) Proteins 0.000 description 1
- AVBHZKNQGDKVEA-ZTKUHGNGSA-N 3-[(2s,3s,7s,8s)-7,13,17-tris(2-carboxyethyl)-3,8,12,18-tetrakis(carboxymethyl)-3,8-dimethyl-2,7,23,24-tetrahydroporphyrin-2-yl]propanoic acid Chemical compound N1C(C=C2C(=C(CC(O)=O)C(=CC=3[C@@]([C@H](CCC(O)=O)C(=C4)N=3)(C)CC(O)=O)N2)CCC(O)=O)=C(CCC(O)=O)C(CC(O)=O)=C1C=C1[C@@H](CCC(O)=O)[C@](C)(CC(O)=O)C4=N1 AVBHZKNQGDKVEA-ZTKUHGNGSA-N 0.000 description 1
- 101710138614 3-oxoacyl-[acyl-carrier-protein] reductase Proteins 0.000 description 1
- 101710095299 3-oxoacyl-[acyl-carrier-protein] reductase FabG Proteins 0.000 description 1
- 101710173786 3-oxoacyl-[acyl-carrier-protein] reductase MabA Proteins 0.000 description 1
- 101710136750 3-oxoacyl-[acyl-carrier-protein] reductase, chloroplastic Proteins 0.000 description 1
- 101710168866 3-oxoacyl-[acyl-carrier-protein] synthase 3 Proteins 0.000 description 1
- 101710130360 3-oxoacyl-[acyl-carrier-protein] synthase III, chloroplastic Proteins 0.000 description 1
- PKYFHKIYHBRTPI-UHFFFAOYSA-N 4-amino-2-methyl-5-phosphooxymethylpyrimidine Chemical compound CC1=NC=C(COP(O)(O)=O)C(N)=N1 PKYFHKIYHBRTPI-UHFFFAOYSA-N 0.000 description 1
- 108010070713 4-amino-5-(hydroxymethyl)-2-methylpyrimidine phosphate kinase Proteins 0.000 description 1
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 1
- VDXLUNDMVKSKHO-XVFCMESISA-N 5'-phosphoribosyl-n-formylglycinamide Chemical compound O[C@H]1[C@@H](O)[C@H](NC(=O)CNC=O)O[C@@H]1COP(O)(O)=O VDXLUNDMVKSKHO-XVFCMESISA-N 0.000 description 1
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- 101710135890 50S ribosomal protein L20 Proteins 0.000 description 1
- 101710135932 50S ribosomal protein L35 Proteins 0.000 description 1
- 108010034869 6-phospho-beta-glucosidase Proteins 0.000 description 1
- PXZWKVIXSKSCFR-UHFFFAOYSA-N 7,8-dihydropterin Chemical compound N1=CCNC2=C1C(=O)N=C(N)N2 PXZWKVIXSKSCFR-UHFFFAOYSA-N 0.000 description 1
- 101710110047 Acetaldehyde dehydrogenase Proteins 0.000 description 1
- 101710124983 Acetaldehyde dehydrogenase (acetylating) Proteins 0.000 description 1
- 241000589220 Acetobacter Species 0.000 description 1
- 241000589212 Acetobacter pasteurianus Species 0.000 description 1
- 101000827329 Acholeplasma phage L2 Uncharacterized 26.1 kDa protein Proteins 0.000 description 1
- 102100031408 Acidic amino acid decarboxylase GADL1 Human genes 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 102100038740 Activator of RNA decay Human genes 0.000 description 1
- 102100022734 Acyl carrier protein, mitochondrial Human genes 0.000 description 1
- 101710144623 Acyl-[acyl-carrier-protein] hydrolase Proteins 0.000 description 1
- 101710174135 Acyl-coenzyme A dehydrogenase Proteins 0.000 description 1
- 102100025291 Adenosine 5'-monophosphoramidase HINT3 Human genes 0.000 description 1
- 101710163058 Adenosine 5'-monophosphoramidase HINT3 Proteins 0.000 description 1
- 102000055025 Adenosine deaminases Human genes 0.000 description 1
- 102100020775 Adenylosuccinate lyase Human genes 0.000 description 1
- 101000916330 Agrobacterium vitis UPF0065 protein in the TAR-I ttuE-ttuC' intergenic region Proteins 0.000 description 1
- 108010041525 Alanine racemase Proteins 0.000 description 1
- 102100039702 Alcohol dehydrogenase class-3 Human genes 0.000 description 1
- 108700023418 Amidases Proteins 0.000 description 1
- 108050005273 Amino acid transporters Proteins 0.000 description 1
- 102000034263 Amino acid transporters Human genes 0.000 description 1
- 101710191958 Amino-acid acetyltransferase Proteins 0.000 description 1
- 108010052434 Aminodeoxychorismate synthase Proteins 0.000 description 1
- 101710180638 Aminodeoxychorismate synthase, chloroplastic Proteins 0.000 description 1
- 102000004400 Aminopeptidases Human genes 0.000 description 1
- 108090000915 Aminopeptidases Proteins 0.000 description 1
- 108090000673 Ammonia-Lyases Proteins 0.000 description 1
- 102000004118 Ammonia-Lyases Human genes 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000192542 Anabaena Species 0.000 description 1
- 108020000948 Antisense Oligonucleotides Proteins 0.000 description 1
- 101100168799 Aquifex aeolicus (strain VF5) csp gene Proteins 0.000 description 1
- 241000219194 Arabidopsis Species 0.000 description 1
- 241000219195 Arabidopsis thaliana Species 0.000 description 1
- 101100062433 Arabidopsis thaliana DHDPS1 gene Proteins 0.000 description 1
- 101100533821 Arabidopsis thaliana FSD1 gene Proteins 0.000 description 1
- 101100312657 Arabidopsis thaliana THRRS gene Proteins 0.000 description 1
- 241001167018 Aroa Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 101000781183 Autographa californica nuclear polyhedrosis virus Uncharacterized 20.4 kDa protein in IAP1-SOD intergenic region Proteins 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 101000786425 Bacillus subtilis (strain 168) Uncharacterized membrane protein YsxD Proteins 0.000 description 1
- 101000762567 Bacillus subtilis (strain 168) Uncharacterized oxidoreductase YhxD Proteins 0.000 description 1
- 101000769186 Bacillus subtilis (strain 168) Uncharacterized protein YpoC Proteins 0.000 description 1
- 101000948224 Bacillus subtilis (strain 168) Uncharacterized protein YtxO Proteins 0.000 description 1
- 101100330872 Bacillus subtilis (strain 168) dctA gene Proteins 0.000 description 1
- 101100170445 Bacillus subtilis (strain 168) dhbB gene Proteins 0.000 description 1
- 101100224392 Bacillus subtilis (strain 168) dpaA gene Proteins 0.000 description 1
- 101100342275 Bacillus subtilis (strain 168) kimA gene Proteins 0.000 description 1
- 101100313657 Bacillus subtilis (strain 168) thiL gene Proteins 0.000 description 1
- 101100532745 Bacillus subtilis (strain 168) yceC gene Proteins 0.000 description 1
- 101100159468 Bacillus subtilis (strain 168) yceG gene Proteins 0.000 description 1
- 101100376045 Bacillus subtilis (strain 168) ydhD gene Proteins 0.000 description 1
- 101100105932 Bacillus subtilis (strain 168) yebE gene Proteins 0.000 description 1
- 101100544700 Bacillus subtilis (strain 168) yobL gene Proteins 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 101710125089 Bindin Proteins 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 102100025399 Breast cancer type 2 susceptibility protein Human genes 0.000 description 1
- 102100032932 COBW domain-containing protein 1 Human genes 0.000 description 1
- 241000244203 Caenorhabditis elegans Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 102000004031 Carboxy-Lyases Human genes 0.000 description 1
- 108090000489 Carboxy-Lyases Proteins 0.000 description 1
- 101710179085 Cardiolipin synthase Proteins 0.000 description 1
- 241001660259 Cereus <cactus> Species 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- 102000034573 Channels Human genes 0.000 description 1
- 108050001186 Chaperonin Cpn60 Proteins 0.000 description 1
- 102000052603 Chaperonins Human genes 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 108090000317 Chymotrypsin Proteins 0.000 description 1
- 101000792152 Citrobacter freundii Uncharacterized 15.0 kDa protein in dhaT-dhaS intergenic region Proteins 0.000 description 1
- 241000193163 Clostridioides difficile Species 0.000 description 1
- 101000752165 Clostridium kluyveri (strain ATCC 8527 / DSM 555 / NCIMB 10680) Uncharacterized transporter CKL_3017 Proteins 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- 101710090244 Cold shock protein CspC Proteins 0.000 description 1
- 101710120163 Cold shock-like protein Proteins 0.000 description 1
- 108060005980 Collagenase Proteins 0.000 description 1
- 102000029816 Collagenase Human genes 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 102100031673 Corneodesmosin Human genes 0.000 description 1
- 101710139375 Corneodesmosin Proteins 0.000 description 1
- 241000252867 Cupriavidus metallidurans Species 0.000 description 1
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 101710116957 D-alanyl-D-alanine carboxypeptidase Proteins 0.000 description 1
- 150000008574 D-amino acids Chemical class 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- LXJXRIRHZLFYRP-VKHMYHEASA-N D-glyceraldehyde 3-phosphate Chemical compound O=C[C@H](O)COP(O)(O)=O LXJXRIRHZLFYRP-VKHMYHEASA-N 0.000 description 1
- 108010092681 DNA Primase Proteins 0.000 description 1
- 102000016559 DNA Primase Human genes 0.000 description 1
- 108090000133 DNA helicases Proteins 0.000 description 1
- 102000003844 DNA helicases Human genes 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 230000033616 DNA repair Effects 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 241000192093 Deinococcus Species 0.000 description 1
- 102100026662 Delta and Notch-like epidermal growth factor-related receptor Human genes 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- 101100004157 Drosophila melanogaster bab1 gene Proteins 0.000 description 1
- 101150013191 E gene Proteins 0.000 description 1
- 108700033886 EC 2.3.1.41 Proteins 0.000 description 1
- 101001131994 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) Proline-specific permease Proteins 0.000 description 1
- 101100491986 Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) aromA gene Proteins 0.000 description 1
- 108090001088 Enoyl-[acyl-carrier-protein] reductase (NADH) Proteins 0.000 description 1
- 101100522027 Enterobacter agglomerans ydiA gene Proteins 0.000 description 1
- 241000702134 Enterobacteria phage 82 Species 0.000 description 1
- 101000791598 Enterobacteria phage 82 Uncharacterized protein in rusA 5'region Proteins 0.000 description 1
- 241000702036 Enterobacteria phage 933W Species 0.000 description 1
- 241000378850 Enterobacteria phage VT2-Sakai Species 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 208000030433 Epiphysiolysis of the hip Diseases 0.000 description 1
- 101000676845 Escherichia coli (strain K12) 50S ribosomal protein L35 Proteins 0.000 description 1
- 101001136699 Escherichia coli (strain K12) Psp operon transcriptional activator Proteins 0.000 description 1
- 101000995602 Escherichia coli (strain K12) Type II NADH:quinone oxidoreductase Proteins 0.000 description 1
- 101100494110 Escherichia coli (strain K12) birA gene Proteins 0.000 description 1
- 101100450615 Escherichia coli (strain K12) hflD gene Proteins 0.000 description 1
- 101100070663 Escherichia coli (strain K12) hinT gene Proteins 0.000 description 1
- 101100401792 Escherichia coli (strain K12) mltG gene Proteins 0.000 description 1
- 101100134981 Escherichia coli (strain K12) opgE gene Proteins 0.000 description 1
- 101100522021 Escherichia coli (strain K12) ppsR gene Proteins 0.000 description 1
- 101100416217 Escherichia coli (strain K12) rlmA gene Proteins 0.000 description 1
- 101100472459 Escherichia coli (strain K12) rluC gene Proteins 0.000 description 1
- 101100417086 Escherichia coli (strain K12) roxA gene Proteins 0.000 description 1
- 101100483065 Escherichia coli (strain K12) ttcA gene Proteins 0.000 description 1
- 101100159304 Escherichia coli (strain K12) ybcN gene Proteins 0.000 description 1
- 101100431686 Escherichia coli (strain K12) ycdY gene Proteins 0.000 description 1
- 101100213151 Escherichia coli (strain K12) ydbH gene Proteins 0.000 description 1
- 101100520153 Escherichia coli pir gene Proteins 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 241001477104 Escherichia virus Wphi Species 0.000 description 1
- 101710091044 Ethanolamine ammonia-lyase large subunit Proteins 0.000 description 1
- 101710183134 Ethanolamine ammonia-lyase small subunit Proteins 0.000 description 1
- 101710153321 Exodeoxyribonuclease 7 large subunit Proteins 0.000 description 1
- 102100037362 Fibronectin Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 101710071060 GMPS Proteins 0.000 description 1
- 108010023555 GTP Cyclohydrolase Proteins 0.000 description 1
- 102100027346 GTP cyclohydrolase 1 Human genes 0.000 description 1
- 108060003306 Galactosyltransferase Proteins 0.000 description 1
- 102000030902 Galactosyltransferase Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 102000000340 Glucosyltransferases Human genes 0.000 description 1
- 108010055629 Glucosyltransferases Proteins 0.000 description 1
- 108050005901 Glutamine amidotransferases Proteins 0.000 description 1
- 101710104222 Glutaredoxin-like protein Proteins 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 102100038261 Glycerol-3-phosphate phosphatase Human genes 0.000 description 1
- 101710186164 Glycerol-3-phosphate regulon repressor Proteins 0.000 description 1
- OBQMLSFOUZUIOB-UHFFFAOYSA-N Glycinamide ribonucleotide Natural products NCC(=O)NC1OC(COP(O)(O)=O)C(O)C1O OBQMLSFOUZUIOB-UHFFFAOYSA-N 0.000 description 1
- 229930189936 Glyoxalase Natural products 0.000 description 1
- 101000600844 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) Probable endopeptidase NlpC homolog Proteins 0.000 description 1
- 101000818057 Haemophilus phage HP1 (strain HP1c1) Uncharacterized 14.9 kDa protein in rep-hol intergenic region Proteins 0.000 description 1
- 101001019450 Haloferax volcanii (strain ATCC 29605 / DSM 3757 / JCM 8879 / NBRC 14742 / NCIMB 2012 / VKM B-1768 / DS2) Isocitrate dehydrogenase [NADP] Proteins 0.000 description 1
- 101710082345 Hemin uptake protein HemP Proteins 0.000 description 1
- 241001523412 Heterorhabditis bacteriophora Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101000678845 Homo sapiens Acyl carrier protein, mitochondrial Proteins 0.000 description 1
- 101000797557 Homo sapiens COBW domain-containing protein 1 Proteins 0.000 description 1
- 101001054266 Homo sapiens Delta and Notch-like epidermal growth factor-related receptor Proteins 0.000 description 1
- 101000937642 Homo sapiens Malonyl-CoA-acyl carrier protein transacylase, mitochondrial Proteins 0.000 description 1
- 101001131930 Homo sapiens Transcriptional activator protein Pur-beta Proteins 0.000 description 1
- 241000193096 Human adenovirus B3 Species 0.000 description 1
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 1
- 208000037309 Hypomyelination of early myelinating structures Diseases 0.000 description 1
- 108010087227 IMP Dehydrogenase Proteins 0.000 description 1
- 102000006674 IMP dehydrogenase Human genes 0.000 description 1
- 108010042653 IgA receptor Proteins 0.000 description 1
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 1
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 1
- 108010061833 Integrases Proteins 0.000 description 1
- 101710148893 Internalin B Proteins 0.000 description 1
- 102000008133 Iron-Binding Proteins Human genes 0.000 description 1
- 108010035210 Iron-Binding Proteins Proteins 0.000 description 1
- 101710174705 Iron-regulated outer membrane virulence protein Proteins 0.000 description 1
- 101710177984 Isocitrate dehydrogenase [NADP] Proteins 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 101001015100 Klebsiella pneumoniae UDP-glucose:undecaprenyl-phosphate glucose-1-phosphate transferase Proteins 0.000 description 1
- 101710113120 L-asparaginase 1 Proteins 0.000 description 1
- 108010012710 L-fuculose-phosphate aldolase Proteins 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 102100023162 L-serine dehydratase/L-threonine deaminase Human genes 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241000204750 Lactococcus phage phi31 Species 0.000 description 1
- 108050008452 Large ribosomal RNA subunit accumulation protein YceD Proteins 0.000 description 1
- 101000827747 Latilactobacillus sakei Uncharacterized 16.5 kDa protein in ptsI 3'region Proteins 0.000 description 1
- 241000283986 Lepus Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 108010006444 Leucine-Rich Repeat Proteins Proteins 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 101710099510 Lysine-specific permease Proteins 0.000 description 1
- 108010053229 Lysyl endopeptidase Proteins 0.000 description 1
- 240000002129 Malva sylvestris Species 0.000 description 1
- 235000006770 Malva sylvestris Nutrition 0.000 description 1
- 241000255908 Manduca sexta Species 0.000 description 1
- 101710184058 Mannose-specific phosphotransferase enzyme IIA component Proteins 0.000 description 1
- 101000626905 Marchantia polymorpha Uncharacterized 3.8 kDa protein in ycf12-psaM intergenic region Proteins 0.000 description 1
- 101001000051 Micromonospora griseorubida Putative 23S rRNA (guanine-N(1)-)-methyltransferase Proteins 0.000 description 1
- 101710121767 MltA-interacting protein Proteins 0.000 description 1
- 108010006519 Molecular Chaperones Proteins 0.000 description 1
- 101710196464 Murein DD-endopeptidase MepS/Murein LD-carboxypeptidase Proteins 0.000 description 1
- 101000823665 Mycolicibacterium smegmatis Uncharacterized 35.9 kDa protein in asd 3'region Proteins 0.000 description 1
- 101000961405 Myxococcus xanthus Uncharacterized 18.1 kDa protein in carS 3'region Proteins 0.000 description 1
- NTNWOCRCBQPEKQ-YFKPBYRVSA-N N(omega)-methyl-L-arginine Chemical compound CN=C(N)NCCC[C@H](N)C(O)=O NTNWOCRCBQPEKQ-YFKPBYRVSA-N 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 108010063372 N-Glycosyl Hydrolases Proteins 0.000 description 1
- 102000010722 N-Glycosyl Hydrolases Human genes 0.000 description 1
- RFMMMVDNIPUKGG-YFKPBYRVSA-N N-acetyl-L-glutamic acid Chemical compound CC(=O)N[C@H](C(O)=O)CCC(O)=O RFMMMVDNIPUKGG-YFKPBYRVSA-N 0.000 description 1
- 101710090468 N-acetylmuramoyl-L-alanine amidase AmiC Proteins 0.000 description 1
- 101710202061 N-acetyltransferase Proteins 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 101710081423 Na(+)/H(+) antiporter 2 Proteins 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 101150029719 P14 gene Proteins 0.000 description 1
- 101710094458 PTS system mannose-specific EIIC component Proteins 0.000 description 1
- 241000531155 Pectobacterium Species 0.000 description 1
- 102000002508 Peptide Elongation Factors Human genes 0.000 description 1
- 108010068204 Peptide Elongation Factors Proteins 0.000 description 1
- 102000056222 Peptide Synthases Human genes 0.000 description 1
- 108700018928 Peptide Synthases Proteins 0.000 description 1
- 101710109393 Peptide transport periplasmic protein SapA Proteins 0.000 description 1
- 108010013639 Peptidoglycan Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 102000007456 Peroxiredoxin Human genes 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 101710199889 Phage shock protein A Proteins 0.000 description 1
- 101710199916 Phage shock protein C Proteins 0.000 description 1
- 108090000430 Phosphatidylinositol 3-kinases Proteins 0.000 description 1
- 102000003993 Phosphatidylinositol 3-kinases Human genes 0.000 description 1
- 102100039654 Phosphoribosylglycinamide formyltransferase Human genes 0.000 description 1
- 102000015082 Phosphoribosylglycinamide formyltransferase Human genes 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 241000224016 Plasmodium Species 0.000 description 1
- 241000223960 Plasmodium falciparum Species 0.000 description 1
- 101000931365 Pneumocystis carinii Dihydropteroate synthase Proteins 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 101710124786 Precorrin-2 C(20)-methyltransferase Proteins 0.000 description 1
- 101710113859 Precorrin-3B C17-methyltransferase Proteins 0.000 description 1
- 101710103630 Precorrin-4 C(11)-methyltransferase Proteins 0.000 description 1
- 101710176328 Precorrin-6Y C(5,15)-methyltransferase [decarboxylating] Proteins 0.000 description 1
- 108030005343 Precorrin-8X methylmutases Proteins 0.000 description 1
- 101710140323 Probable Thioredoxin Proteins 0.000 description 1
- 101710152708 Probable adenosine deaminase Proteins 0.000 description 1
- 101710134548 Probable enoyl-CoA hydratase Proteins 0.000 description 1
- 102100034014 Prolyl 3-hydroxylase 3 Human genes 0.000 description 1
- 101710146106 Propanal dehydrogenase (CoA-propanoylating) Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 101710180316 Protease 2 Proteins 0.000 description 1
- 101710188053 Protein D Proteins 0.000 description 1
- 101710132807 Protein P5 Proteins 0.000 description 1
- 101710188306 Protein Y Proteins 0.000 description 1
- 101710150114 Protein rep Proteins 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000588778 Providencia stuartii Species 0.000 description 1
- 101100162215 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) agmR gene Proteins 0.000 description 1
- 101000892429 Pseudomonas aeruginosa Type II restriction enzyme PaeR7I Proteins 0.000 description 1
- 241000589540 Pseudomonas fluorescens Species 0.000 description 1
- 241001428540 Pseudomonas virus D3 Species 0.000 description 1
- 108030005599 Pseudouridylate synthases Proteins 0.000 description 1
- 101710167959 Putative UTP-glucose-1-phosphate uridylyltransferase Proteins 0.000 description 1
- 101710165374 Putative helicase Proteins 0.000 description 1
- 101710104908 Putative permease PerM Proteins 0.000 description 1
- 101710139094 Putative protein p17 Proteins 0.000 description 1
- 101710194805 Putative repressor Proteins 0.000 description 1
- 108010070648 Pyridoxal Kinase Proteins 0.000 description 1
- 101710168781 Pyridoxine-5'-phosphate oxidase Proteins 0.000 description 1
- 101710136147 Pyridoxine/pyridoxamine 5'-phosphate oxidase Proteins 0.000 description 1
- 241000205160 Pyrococcus Species 0.000 description 1
- 101100328743 Pyrococcus abyssi (strain GE5 / Orsay) cobD gene Proteins 0.000 description 1
- 241000522615 Pyrococcus horikoshii Species 0.000 description 1
- 108020005115 Pyruvate Kinase Proteins 0.000 description 1
- 102000013009 Pyruvate Kinase Human genes 0.000 description 1
- 108010066717 Q beta Replicase Proteins 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 108090001066 Racemases and epimerases Proteins 0.000 description 1
- 102000004879 Racemases and epimerases Human genes 0.000 description 1
- 108700005075 Regulator Genes Proteins 0.000 description 1
- 101710182484 Regulatory protein PqrA Proteins 0.000 description 1
- 101710152114 Replication protein Proteins 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 102000009661 Repressor Proteins Human genes 0.000 description 1
- 101710132893 Resolvase Proteins 0.000 description 1
- 241000589180 Rhizobium Species 0.000 description 1
- 102000004285 Ribosomal Protein L3 Human genes 0.000 description 1
- 108090000894 Ribosomal Protein L3 Proteins 0.000 description 1
- 235000017304 Ruaghas Nutrition 0.000 description 1
- 241000554738 Rusa Species 0.000 description 1
- 101710128618 S-acyl fatty acid synthase thioesterase Proteins 0.000 description 1
- NAQGHJTUZRHGAC-ZZZDFHIKSA-N SAICAR Chemical compound NC1=C(C(=O)N[C@@H](CC(O)=O)C(O)=O)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 NAQGHJTUZRHGAC-ZZZDFHIKSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 101001086533 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) tRNA pseudouridine(31) synthase Proteins 0.000 description 1
- 241000701835 Salmonella virus P22 Species 0.000 description 1
- 102100023522 Selenide, water dikinase 2 Human genes 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 102100035717 Serine racemase Human genes 0.000 description 1
- 108010006152 Serine racemase Proteins 0.000 description 1
- 101000992423 Severe acute respiratory syndrome coronavirus 2 Putative ORF9c protein Proteins 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 101710084578 Short neurotoxin 1 Proteins 0.000 description 1
- 241000589127 Sinorhizobium fredii NGR234 Species 0.000 description 1
- 101710133109 Sodium/proton antiporter 2 Proteins 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 101000758230 Streptomyces ambofaciens Uncharacterized 19.3 kDa protein in repSA 5'region Proteins 0.000 description 1
- 101100197084 Streptomyces coelicolor (strain ATCC BAA-471 / A3(2) / M145) rpmF1 gene Proteins 0.000 description 1
- 241001446311 Streptomyces coelicolor A3(2) Species 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 101710135785 Subtilisin-like protease Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 101000693115 Sulfurisphaera tokodaii (strain DSM 16993 / JCM 10545 / NBRC 100140 / 7) Sugar-1-phosphate acetyltransferase Proteins 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 241000248418 Tetrahymena pyriformis Species 0.000 description 1
- 102000002933 Thioredoxin Human genes 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 102100033451 Thyroid hormone receptor beta Human genes 0.000 description 1
- 101710182223 Toxin B Proteins 0.000 description 1
- 101710182532 Toxin a Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 108010020713 Tth polymerase Proteins 0.000 description 1
- 101710189180 Type II restriction enzyme PaeR7I Proteins 0.000 description 1
- HSCJRCZFDFQWRP-RDKQLNKOSA-N UDP-D-glucose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-RDKQLNKOSA-N 0.000 description 1
- 101710100170 Unknown protein Proteins 0.000 description 1
- HSCJRCZFDFQWRP-UHFFFAOYSA-N Uridindiphosphoglukose Natural products OC1C(O)C(O)C(CO)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 101100226309 Vibrio cholerae serotype O1 (strain ATCC 39315 / El Tor Inaba N16961) exbB1 gene Proteins 0.000 description 1
- 101710169746 Virulence-associated protein A Proteins 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 108010006886 Vitrogen Proteins 0.000 description 1
- 241001148113 Xanthomonas albilineans Species 0.000 description 1
- 241000607735 Xenorhabdus nematophila Species 0.000 description 1
- 241000607477 Yersinia pseudotuberculosis Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 241000588902 Zymomonas mobilis Species 0.000 description 1
- 101710154275 [Acyl-carrier-protein] malonyltransferase Proteins 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 108091006088 activator proteins Proteins 0.000 description 1
- 230000006154 adenylylation Effects 0.000 description 1
- 101150014383 adhE gene Proteins 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 description 1
- 102000005922 amidase Human genes 0.000 description 1
- 229940064734 aminobenzoate Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical group 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000000074 antisense oligonucleotide Substances 0.000 description 1
- 238000012230 antisense oligonucleotides Methods 0.000 description 1
- 101150037081 aroA gene Proteins 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 108010056458 bacterial fibronectin-binding proteins Proteins 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 102000006995 beta-Glucosidase Human genes 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- WOUDXEYYJPOSNE-VKZDFBPFSA-N bicozamycin Chemical compound N1C(=O)[C@@]2(O)NC(=O)[C@]1([C@@H](O)[C@@](O)(CO)C)OCCC2=C WOUDXEYYJPOSNE-VKZDFBPFSA-N 0.000 description 1
- WOUDXEYYJPOSNE-UHFFFAOYSA-N bicyclomycin Natural products N1C(=O)C2(O)NC(=O)C1(C(O)C(O)(CO)C)OCCC2=C WOUDXEYYJPOSNE-UHFFFAOYSA-N 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000001486 biosynthesis of amino acids Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 101150098767 btuR gene Proteins 0.000 description 1
- AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- UUDRLGYROXTISK-UHFFFAOYSA-N carbamimidoylazanium;iodide Chemical compound I.NC(N)=N UUDRLGYROXTISK-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 125000001721 carboxyacetyl group Chemical group 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 229960002376 chymotrypsin Drugs 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 102000005328 cob(I)alamin adenosyltransferase Human genes 0.000 description 1
- 108020002592 cob(I)alamin adenosyltransferase Proteins 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- XQRJFEVDQXEIAX-JFYQDRLCSA-M cobinamide Chemical compound [Co]N([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@H](O)C)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O XQRJFEVDQXEIAX-JFYQDRLCSA-M 0.000 description 1
- 108010012421 cobinamide kinase Proteins 0.000 description 1
- 229960002424 collagenase Drugs 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 239000012468 concentrated sample Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 101150110403 cspA gene Proteins 0.000 description 1
- 101150107437 cspC gene Proteins 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 102000030626 cysteine desulfurase Human genes 0.000 description 1
- 108091000099 cysteine desulfurase Proteins 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 231100000599 cytotoxic agent Toxicity 0.000 description 1
- 239000002619 cytotoxin Substances 0.000 description 1
- RGWHQCVHVJXOKC-SHYZEUOFSA-N dCTP Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OP(O)(O)=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-N 0.000 description 1
- GYOZYWVXFNDGLU-XLPZGREQSA-N dTMP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)C1 GYOZYWVXFNDGLU-XLPZGREQSA-N 0.000 description 1
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 101150000582 dapE gene Proteins 0.000 description 1
- 230000000911 decarboxylating effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 229960002086 dextran Drugs 0.000 description 1
- 229940041984 dextran 1 Drugs 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 108020000862 enoyl-CoA hydratase/isomerase Proteins 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 108091023030 exopolyphosphatase Proteins 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 101150100150 fabI gene Proteins 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 238000009432 framing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 101150041954 galU gene Proteins 0.000 description 1
- 101150021028 gcvR gene Proteins 0.000 description 1
- 238000001641 gel filtration chromatography Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 101150115690 gloA gene Proteins 0.000 description 1
- 101150097706 glpR gene Proteins 0.000 description 1
- 229950010772 glucose-1-phosphate Drugs 0.000 description 1
- OBQMLSFOUZUIOB-SHUUEZRQSA-N glycineamide ribonucleotide Chemical compound NCC(=O)N[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O OBQMLSFOUZUIOB-SHUUEZRQSA-N 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 101150079176 grxD gene Proteins 0.000 description 1
- 101150096208 gtaB gene Proteins 0.000 description 1
- 108010064833 guanylyltransferase Proteins 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- BTIJJDXEELBZFS-QDUVMHSLSA-K hemin Chemical compound CC1=C(CCC(O)=O)C(C=C2C(CCC(O)=O)=C(C)\C(N2[Fe](Cl)N23)=C\4)=N\C1=C/C2=C(C)C(C=C)=C3\C=C/1C(C)=C(C=C)C/4=N\1 BTIJJDXEELBZFS-QDUVMHSLSA-K 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 108010037896 heparin-binding hemagglutinin Proteins 0.000 description 1
- 210000001990 heterocyst Anatomy 0.000 description 1
- 101150046765 higB gene Proteins 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 101150068015 holB gene Proteins 0.000 description 1
- 108010071598 homoserine kinase Proteins 0.000 description 1
- 210000004408 hybridoma Anatomy 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 101150077022 icmF gene Proteins 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 229940127121 immunoconjugate Drugs 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000126 in silico method Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- ALDIVIWLBSDGGN-ONEGZZNKSA-N indigoidine Chemical compound O=C1NC(=O)C(N)=C\C1=C\1C(=O)NC(=O)C(N)=C/1 ALDIVIWLBSDGGN-ONEGZZNKSA-N 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 210000004901 leucine-rich repeat Anatomy 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 238000007834 ligase chain reaction Methods 0.000 description 1
- 238000001638 lipofection Methods 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 239000000891 luminescent agent Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- LTYOQGRJFJAKNA-VFLPNFFSSA-N malonyl-coa Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSC(=O)CC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 LTYOQGRJFJAKNA-VFLPNFFSSA-N 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 108020004084 membrane receptors Proteins 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012269 metabolic engineering Methods 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 238000000302 molecular modelling Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 108010002832 murein transglycosylase Proteins 0.000 description 1
- 101150072263 mutT gene Proteins 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 230000036438 mutation frequency Effects 0.000 description 1
- 238000002663 nebulization Methods 0.000 description 1
- JOUIQRNQJGXQDC-ZYUZMQFOSA-L nicotinate D-ribonucleotide(2-) Chemical compound O1[C@H](COP([O-])([O-])=O)[C@@H](O)[C@@H](O)[C@@H]1[N+]1=CC=CC(C([O-])=O)=C1 JOUIQRNQJGXQDC-ZYUZMQFOSA-L 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 101150105776 nosD gene Proteins 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 102000022744 oligopeptide binding proteins Human genes 0.000 description 1
- 108091013547 oligopeptide binding proteins Proteins 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 101150054449 pagP gene Proteins 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 101150084718 pdxH gene Proteins 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 108030002458 peroxiredoxin Proteins 0.000 description 1
- 230000000361 pesticidal effect Effects 0.000 description 1
- 101150028857 phoP gene Proteins 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229930029653 phosphoenolpyruvate Natural products 0.000 description 1
- SVFDQCDOCFVPKQ-UHFFFAOYSA-N phosphomethylpyrimidine Chemical compound O=P(=O)CC1=NC=CC=N1 SVFDQCDOCFVPKQ-UHFFFAOYSA-N 0.000 description 1
- DTBNBXWJWCWCIK-UHFFFAOYSA-K phosphonatoenolpyruvate Chemical compound [O-]C(=O)C(=C)OP([O-])([O-])=O DTBNBXWJWCWCIK-UHFFFAOYSA-K 0.000 description 1
- 239000005080 phosphorescent agent Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000004481 post-translational protein modification Effects 0.000 description 1
- 101150067185 ppsA gene Proteins 0.000 description 1
- OQIIYZQTTMKFAU-ZNLOQLQNSA-N precorrin-2 Chemical compound N1C2=C(CCC(O)=O)C(CC(O)=O)=C1/C=C(N/1)/[C@@H](CCC(O)=O)[C@](C)(CC(O)=O)C\1=C\C([C@@H](CCC(O)=O)[C@]1(C)CC(O)=O)=N\C1=C/C(N1)=C(CC(O)=O)C(CCC(O)=O)=C1C2 OQIIYZQTTMKFAU-ZNLOQLQNSA-N 0.000 description 1
- 108010002047 precorrin-2 O-methyltransferase Proteins 0.000 description 1
- IGCZFSMEIXUSJY-FKUSVXTQSA-N precorrin-8X Chemical compound N([C@H]([C@@H]([C@]1(CCC(O)=O)C)CC(O)=O)[C@@]2(N=C([C@H]([C@@]2(CC(O)=O)C)CCC(O)=O)\C(C)=C2/N=C([C@H]([C@@]2(CC(O)=O)C)CCC(O)=O)C2)C)=C1C(C)C1=N[C@]2(C)C(C)=C1CCC(O)=O IGCZFSMEIXUSJY-FKUSVXTQSA-N 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 108010049718 pseudouridine synthases Proteins 0.000 description 1
- 101150019395 pspB gene Proteins 0.000 description 1
- 238000003906 pulsed field gel electrophoresis Methods 0.000 description 1
- 238000003751 purification from natural source Methods 0.000 description 1
- 239000002213 purine nucleotide Substances 0.000 description 1
- 229960003581 pyridoxal Drugs 0.000 description 1
- 235000008164 pyridoxal Nutrition 0.000 description 1
- 239000011674 pyridoxal Substances 0.000 description 1
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 1
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 1
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 1
- ZMJGSOSNSPKHNH-UHFFFAOYSA-N pyridoxamine 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(CN)=C1O ZMJGSOSNSPKHNH-UHFFFAOYSA-N 0.000 description 1
- 235000008974 pyridoxamine 5'-phosphate Nutrition 0.000 description 1
- 239000011580 pyridoxamine 5'-phosphate Substances 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 230000018612 quorum sensing Effects 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 108090000589 ribonuclease E Proteins 0.000 description 1
- 108020004418 ribosomal RNA Proteins 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 229920002477 rna polymer Polymers 0.000 description 1
- 101150027045 rplY gene Proteins 0.000 description 1
- 101150059313 rpmF gene Proteins 0.000 description 1
- 101150001839 rsuA gene Proteins 0.000 description 1
- 230000022932 ruffle assembly Effects 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 101150106205 sapD gene Proteins 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 150000003346 selenoethers Chemical class 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 101150018269 sodB gene Proteins 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- ICNXOXCTOLGHIJ-UHFFFAOYSA-J tetrasodium 5-[[4-[4-[(3-carboxylato-4-oxidophenyl)diazenyl]-2-sulfophenyl]-3-sulfophenyl]diazenyl]-2-oxidobenzoate Chemical compound [Na+].[Na+].[Na+].[Na+].Oc1ccc(cc1C([O-])=O)N=Nc1ccc(-c2ccc(cc2S([O-])(=O)=O)N=Nc2ccc(O)c(c2)C([O-])=O)c(c1)S([O-])(=O)=O ICNXOXCTOLGHIJ-UHFFFAOYSA-J 0.000 description 1
- 238000005382 thermal cycling Methods 0.000 description 1
- 150000007970 thio esters Chemical class 0.000 description 1
- 108060008226 thioredoxin Proteins 0.000 description 1
- 229940094937 thioredoxin Drugs 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 230000007888 toxin activity Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 108091006106 transcriptional activators Proteins 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 102000035160 transmembrane proteins Human genes 0.000 description 1
- 108091005703 transmembrane proteins Proteins 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 229960001322 trypsin Drugs 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 229940035893 uracil Drugs 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- HUHWZXWWOFSFKF-UHFFFAOYSA-N uroporphyrinogen-III Chemical compound C1C(=C(C=2CCC(O)=O)CC(O)=O)NC=2CC(=C(C=2CCC(O)=O)CC(O)=O)NC=2CC(N2)=C(CC(O)=O)C(CCC(=O)O)=C2CC2=C(CCC(O)=O)C(CC(O)=O)=C1N2 HUHWZXWWOFSFKF-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 108010062110 water dikinase pyruvate Proteins 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 101150091741 ycfH gene Proteins 0.000 description 1
- 101150043173 ychJ gene Proteins 0.000 description 1
- 101150032166 yciB gene Proteins 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 101150018525 yebF gene Proteins 0.000 description 1
- 101150049014 yejG gene Proteins 0.000 description 1
- 101150053022 yejK gene Proteins 0.000 description 1
- 101150096604 yejL gene Proteins 0.000 description 1
- 101150032601 yejM gene Proteins 0.000 description 1
- 101150075080 yuaU gene Proteins 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
Definitions
- the subject of the invention is the genomic sequence and nucleotide sequences coding for photorhabdus luminescens polypeptides, such as polypeptides involved in operons for biosynthesis of antibiotics, or toxins, or polypeptides with activity of toxin or antibiotic type which can be used as a pesticide, bactericide or fungicide as well as vectors including said sequences and cells or animals transformed by these vectors.
- Photorhabdus luminescens is an entomopathogenic bacteria, intestinal commensal of a nematode and insect parasite.
- This bacterium is both a model for the study of host-parasite interactions and a bacterium whose industrial applications are numerous due to its ability to synthesize many toxins (insecticides, bactericides and fungicides) and to secrete many enzymes.
- the photorhabdus luminescens genome has been sequenced.
- the present invention thus relates to the nucleotide and polypeptide sequences of Photorhabdus luminescens strain TT01.
- the Photorhabdus luminescens TT01 strain is also identified in the present application by Photorhabdus luminescens, interchangeably.
- the invention also relates to new tools for typing strains of Photorhabdus. These tools could be of the DNA "chip” type or of another type. The new features of these typing tools will be as follows:
- the present invention therefore relates to an isolated nucleotide sequence derived from the genome of Photorhabdus luminescens, characterized in that it comprises a sequence chosen from the sequences SEQ ID No. 1 to SEQ ID No. 41 and the sequences SEQ ID No. 5826 to SEQ ID No. 5834.
- sequences SEQ ID No. 1 to SEQ ID No. 41 represent the sequences of 41 contigs, the whole of which covers the genomic sequence of Photorhabdus luminescens TTOl.
- sequences SEQ 1) N ° 1 to SEQ ID N ° 41 could be reassembled and reread in 9 new contigs, all of which also covers the genomic sequence of Photorhabdus luminescens TTOl.
- sequences SEQ ID N ° 5826 to SEQ ID N ° 5834 represent the sequences of these 9 contigs
- the nucleotide sequences SEQ ID No.1 to SEQ ID No.41 and SEQ ID No.5826 to SEQ ID No.5834 were obtained by sequencing the genome of Photorhabdus luminescens TTOl by the so-called shot-gun technique (cf. Examples) .
- shot-gun technique cf. Examples
- SEQ ⁇ ) N ° 1 to SEQ ⁇ ) N ° 41 or SEQ ⁇ ) N ° 5826 to SEQ ⁇ ) N ° 5834 it is possible that these do not represent perfectly 100 % after assembly the nucleotide sequence of the genome of Photorhabdus luminescens TTOl and that some rare sequencing errors or indeterminacies remain in these sequences.
- the corrected nucleotide sequence obtained would still comprise at least 97%, preferably at least 98%, 98.5%, 99% or 99.9% of identity with the genomic sequence obtained after assembly of these nucleotide sequences SEQ ⁇ ) N ° 1 to SEQ ⁇ ) N ° 41 or SEQ ⁇ ) N ° 5826 to SEQ ⁇ ) N ° 5834.
- the present invention also relates to an isolated nucleotide sequence derived from the Photorhabdus luminescens genome, characterized in that it is chosen from: a) a nucleotide sequence comprising at least 75%, 80%, 85%, 90%, 95%, 98% or 99% identity with a sequence chosen from the sequences SEQ ⁇ )
- the present invention also relates to a nucleotide sequence included in one of the sequences SEQ ⁇ ) N ° 1 to SEQ ⁇ ) N ° 41 or one of the sequences SEQ ⁇ ) N ° 5826 to SEQ ⁇ ) N ° 5834 , and in that it codes for a polypeptide chosen from the polypeptides of sequence SEQ ⁇ ) N ° 42 to SEQ ⁇ ) N ° 3855 or from the polypeptides coded by a sequence SEQ ⁇ ) N ° 5835 to SEQ ⁇ ) N ° 10784.
- SEQ ⁇ ) N ° 10784 are the polypeptides whose sequence of at least 5 amino acids is obtained by taking as reading frame the first nucleotide of the sequences SEQ ⁇ ) N ° 5835 to SEQ ⁇ ) N ° 10784.
- the invention also relates to a nucleotide sequence, characterized in that it codes for a polypeptide whose function annotated in Table I below, last column or in Table ⁇ below, penultimate column, corresponds to a toxin and / or antibiotic type activity, or to an operon involved in the synthesis of toxin and / or antibiotic, polypeptide preferably chosen from: a) polypeptides of sequences SEQ 1), No.
- polypeptides of sequence as defined in paragraph a) above the function of which is associated with a toxin or antibiotic type activity, or their homologous polypeptide from Table ⁇ as defined in paragraph b) above, have could be identified, for example, by the presence of a consensus motif linked to these functions or by the presence of sequences adjoining them on the genome and involved in this type of activity.
- the present invention also relates more generally to the nucleotide sequences originating from SEQ ⁇ ) N ° 1 to SEQ ⁇ ) N ° 41 or SEQ ⁇ ) N ° 5826 to SEQ ⁇ )
- nucleotide sequences characterized in that they comprise a nucleotide sequence chosen from: a) a nucleotide sequence coding for a polypeptide chosen from the sequences SEQ ⁇ ) N ° 42 to SEQ ⁇ ) N ° 3855 or from the encoded polypeptides by the sequences SEQ 1) No. 5835 to SEQ 1) No.
- 10784 preferably from the 82 sequences of polypeptides above selected for their function associated with an activity of toxin or antibiotic type or their homologous peptide as defined in the table ⁇ in the last column; b) a nucleotide sequence comprising at least 75% identity with a nucleotide sequence as defined in a), preferably at least 80%, 85%,
- c) a complementary nucleotide or RNA sequence corresponding to a sequence as defined in a) or b); d) a nucleotide sequence of a fragment representative of a sequence as defined in a) or c); and e) a sequence as defined in a), or c) modified, are also objects of the invention.
- nucleic acid nucleic or nucleic acid sequence, polynucleotide, ohgonucleotide, polynucleotide sequence, nucleotide sequence, terms which will be used interchangeably in the present description, is intended to denote a precise sequence of nucleotides, modified or not, making it possible to define a fragment or region of a nucleic acid, which may or may not contain unnatural nucleotides, and which may correspond both to double-stranded DNA, single-stranded DNA and to transcripts of said DNAs.
- the nucleic acid sequences according to the invention also include PNA (Peptid Nucleic Acid).
- nucleotide sequences in their natural chromosomal environment that is to say in the natural state. These are sequences which have been isolated and / or purified, that is to say that they have have been taken directly or indirectly, for example by copy, their environment having been at least partially modified. This also means the nucleic acids obtained by chemical synthesis.
- percentage of identity between two nucleic acid or amino acid sequences within the meaning of the present invention is meant a percentage of identical nucleotides or amino acid residues between the two sequences to be compared, obtained after the best alignment, this percentage being purely statistical and the differences between the two sequences being distributed randomly and over their entire length.
- the term “best alignment” or “optimal alignment” is intended to denote the alignment for which the percentage of identity determined as below is the highest. Sequence comparisons between two nucleic acid or amino acid sequences are traditionally carried out by comparing these sequences after having optimally aligned them, said comparison being carried out by segment or by "comparison window" to identify and compare the regions. sequence similarity locale.
- the optimal alignment of the sequences for comparison can be achieved, besides manually, by means of the local homology algorithm of Smith and Waterman (1981, Ad. App. Math., 2: 482), by means of the local homology algorithm of Neddleman and Wunsch (1970, J. Mol. Biol., 48: 443), using the similarity search method of Pearson and Lipman (1988, Proc. Natl. Acad. Sci. USA, 85: 2444), using computer software using these algorithms (GAP, BESTFIT, BLAST P, BLAST N, FASTA and TFASTA in the Wisconsin Genetics Software Package, Genetics Computer Group, 575 Science Dr., Madison, WI).
- the BLAST program is preferably used with the BLOSUM 62 matrix.
- the PAM or PAM250 matrices can also be used.
- the percentage of identity between two nucleic acid or amino acid sequences is determined by comparing these two optimally aligned sequences, the nucleic acid or amino acid sequence to be compared can include additions or deletions by compared to the reference sequence for optimal alignment between these two sequences.
- the percentage identity is calculated by determining the number of identical positions for which the nucleotide or the amino acid residue is identical in the two sequences, by dividing this number of identical positions by the total number of positions compared and by multiplying the result obtained by 100 to obtain the percentage of identity between these two sequences.
- nucleic acid sequences having a percentage identity of at least 75%, preferably 80%, 85%, 90%, 95%, 98% or 99%, after optimal alignment with a reference sequence is meant the sequences nucleic acids presenting, with respect to the reference nucleic acid sequence, certain modifications such as in particular a deletion, a truncation, an elongation, a chimeric fusion and / or a substitution, in particular punctual, and whose nucleic sequence presents at least 75%, preferably 80%, 85%, 90%, 95%, 98% or 99% of identity after optimal alignment with the reference nucleic sequence.
- They are preferably sequences whose complementary sequences are capable of hybridizing specifically with the reference sequences.
- the specific hybridization conditions or high stringency will be such that they ensure at least 75%, preferably 80%, 85%, 90%, 95%, 98% or 99% of identity after optimal alignment between one of the two sequences and its complementary sequence.
- Hybridization under conditions of high stringency means that the conditions of temperature and ionic strength are chosen in such a way that they allow hybridization to be maintained between two complementary DNA fragments.
- high stringency conditions of the hybridization step for the purpose of defining the polynucleotide fragments described above are advantageously as follows.
- DNA-DNA or DNA-RNA hybridization is carried out in two stages: (1) prehybridization at 42 ° C for 3 hours in phosphate buffer (20 mM, pH 7.5) containing 5 x SSC (1 x SSC corresponds to a 0.15 M NaCl + 0.015 M sodium citrate solution), 50% formamide, 7% sodium dodecyl sulfate (SDS), 10 x Denhardt's, 5% dextran sulfate and 1% salmon sperm DNA; (2) actual hybridization for 20 hours at a temperature depending on the size of the probe (ie: 42 ° C, for a probe of size> 100 nucleotides) followed by 2 washes of 20 minutes at 20 ° C in 2 x SSC + 2% SDS, 1 wash for 20 minutes at 20 ° C in 0.1 x SSC + 0.1% SDS.
- the last washing is carried out in 0.1 ⁇ SSC + 0.1% SDS for 30 minutes at 60 ° C. for a probe of size> 100 nucleotides.
- the high stringency hybridization conditions described above for a polynucleotide of defined size can be adapted by the skilled person for oligonucleotides of larger or smaller size, according to the teaching of Sambrook et al. (1989, Molecular cloning: a laboratory manual. 2 nd Ed. Cold Spring Harbor).
- fragment representative of sequences according to the invention is intended to denote any nucleotide fragment having at least 15 nucleotides, preferably at least 20, 25, 30, 50, 75, 100, 150, 200, 300 and 450 consecutive nucleotides.
- representative fragment in particular a nucleic sequence coding for a biologically active fragment of a polypeptide, as defined below.
- representative fragment is also meant the intergenic sequences, and in particular the nucleotide sequences carrying the regulatory signals (promoters, terminators, or even enhancers, etc.).
- the numbering of the ORFs nucleotide sequences which will be used subsequently in the present description corresponds to the numbering of the amino acid sequences of the proteins encoded by said ORFs for the sequences SEQ 1) No. 42 to SEQ 1) No. 3855.
- the numbering of the nucleotide sequences ORFs SEQ ⁇ ) N ° 5835 to SEQ ⁇ ) N ° 10784 will be used subsequently in the present description for the numbering of the amino acid sequences of the proteins coded by said ORFs SEQ ⁇ ) N ° 5835 to SEQ II) No. 10784.
- the representative fragments according to the invention can be obtained for example by specific amplification such as PCR or after digestion with appropriate restriction enzymes of nucleotide sequences according to the invention, this method being described in particular in the book by Sambrook et al. .. Said representative fragments can also be obtained by chemical synthesis when their size is not too large, according to methods well known to those skilled in the art.
- sequences containing sequences of the invention or representative fragments, one also understands the sequences which are naturally framed by sequences which present at least 75%, 80%, 85%, 90%, 95%, 98% or 99% identity with the sequences according to the invention.
- modified nucleotide sequence any nucleotide sequence obtained by mutagenesis according to techniques well known to those skilled in the art, and comprising modifications with respect to the normal sequences, preferably at most 10% of nucleotides modified with respect to these normal sequences, for example mutations in the regulatory and / or promoter sequences for the expression of the polypeptide, in particular leading to a modification of the expression or activity level of said polypeptide.
- modified nucleotide sequence is also meant any nucleotide sequence coding for a modified polypeptide as defined below.
- the representative fragments according to the invention can also be probes or primers, which can be used in methods of detection, identification, assay or amplification of nucleic sequences.
- a probe or primer is defined, within the meaning of the invention, as being a fragment of single-stranded nucleic acids or a denatured double-stranded fragment comprising for example from 12 bases to a few kb, in particular from 15 to a few hundred bases, preferably from 15 to 50 or 100 bases, and having a specificity of hybridization under determined conditions to form a hybridization complex with a target nucleic acid.
- the probes and primers according to the invention can be labeled directly or indirectly with a radioactive or non-radioactive compound by methods well known to those skilled in the art, in order to obtain a detectable and / or quantifiable signal (patent FR 78 10975 and bDNA of Chiron EP 225 807 and EP 510 085).
- the unlabeled polynucleotide sequences according to the invention can be used directly as a probe or primer.
- sequences are generally marked to obtain sequences which can be used for numerous applications.
- the labeling of the primers or probes according to the invention is carried out with radioactive elements or with non-radioactive molecules.
- Non-radioactive entities are selected from ligands such as biotin, avidin, streptavidin, dioxygenin, haptens , dyes, luminescent agents such as radioluminescent, chemoluminescent, bioluminescent, fluorescent, phosphorescent agents.
- the polynucleotides according to the invention can thus be used as a primer and / or probe in methods using in particular the PCR technique (polymerase chain reaction) (Rolfs et al., 1991, Berlin: Springer-Verlag).
- This technique requires the choice of pairs of oligonucleotide primers framing the fragment which must be amplified.
- the amplified fragments can be identified, for example after agarose or polyacrylamide gel electrophoresis, or after a chromatographic technique such as gel filtration or ion exchange chromatography, and then sequenced.
- the specificity of the amplification can be controlled by using the nucleotide sequences of polynucleotides of the invention as template, plasmids containing these sequences or even the amplification products derived therefrom.
- the amplified nucleotide fragments can be used as reagents in hybridization reactions in order to demonstrate the presence, in a biological sample, of a target nucleic acid of sequence complementary to that of said amplified nucleotide fragments.
- the invention also relates to the nucleic acids capable of being obtained by amplification using primers according to the invention.
- Other techniques for amplifying the target nucleic acid can advantageously be used as an alternative to PCR (PCR-like) using pairs of primers of nucleotide sequences according to the invention.
- PCR-like is meant to denote all the methods implementing direct or indirect reproductions of the nucleic acid sequences, or in which the labeling systems have been amplified, these techniques are of course known. In general, it is the amplification of DNA by a polymerase; when the original sample is an RNA, a reverse transcription should be carried out beforehand.
- the target polynucleotide to be detected is an mRNA
- an enzyme of reverse transcriptase type in order to obtain a cDNA from the mRNA contained in the biological sample.
- the cDNA obtained will then serve as a target for the primers or probes used in the amplification or detection method according to the invention.
- the probe hybridization technique can be performed in various ways (Matthews et al., 1988, Anal. Biochem., 169, 1-25).
- the most general method consists in immobilizing the nucleic acid extracted from cells of different tissues or cells in culture on a support (such as nitrocellulose, nylon, polystyrene) and incubating, under well defined conditions, the target nucleic acid immobilized with the probe. After hybridization, the excess probe is eliminated and the hybrid molecules formed are detected by the appropriate method (measurement of radioactivity, fluorescence or enzymatic activity linked to the probe).
- the latter can be used as capture probes.
- a probe called a “capture probe”
- a probe is immobilized on a support and is used to capture by specific hybridization the target nucleic acid obtained from the biological sample to be tested and the target nucleic acid is then detected.
- a second probe called a “detection probe”, marked by an easily detectable element.
- the antisense oligonucleotides that is to say those whose structure ensures, by hybridization with the target sequence, an inhibition of the expression of the corresponding product. Mention should also be made of sense oligonucleotides which, by interaction with proteins involved in the regulation of the expression of the corresponding product, will induce either an inhibition or an activation of this expression.
- the probes or primers according to the invention are immobilized on a support, covalently or non-covalently.
- the support can be a DNA chip or a high or medium density filter, also subject of the present invention (patents WO 97/29212, WO 98/27317, WO 97/10365 and WO 92/10588).
- DNA chip or high density filter is intended to denote a support on which DNA sequences are fixed, each of which can be identified by its geographic location. These chips or filters differ mainly in their size, the material of the support, and possibly the number of DNA sequences attached to them.
- the probes or primers according to the first invention can be fixed on solid supports, in particular DNA chips, by various manufacturing methods.
- a synthesis can be carried out in situ by photochemical addressing or by ink jet.
- Other techniques consist in carrying out an ex situ synthesis and in fixing the probes on the support of the DNA chip by mechanical, electronic or inkjet addressing. These different methods are well known to those skilled in the art.
- a nucleotide sequence (probe or primer) according to the invention therefore allows the detection and / or amplification of specific nucleic sequences.
- the detection of these said sequences is facilitated when the probe is fixed to a DNA chip, or to a high density filter.
- DNA chips or high density filters makes it possible to determine the expression of genes in an organism having a genomic sequence close to P. luminescens and the typing of the strain in question.
- the genomic sequence of P. luminescens supplemented by the identification of the genes of these organisms, as presented in the present invention, serve as the basis for the construction of these DNA chips or filter.
- the preparation of these filters or chips consists in synthesizing oligonucleotides, corresponding to the 5 ′ and 3 ′ ends of the genes or to more internal fragments to amplify fragments of a suitable size, for example between approximately 300 and 800 bases.
- oligonucleotides are chosen using the genomic sequence and its annotations disclosed by the present invention.
- the pairing temperature of these oligonucleotides at the corresponding places on the DNA must be approximately the same for each oligonucleotide. This makes it possible to prepare DNA fragments corresponding to each gene by the use of appropriate PCR conditions in a highly automated environment.
- the amplified fragments are then immobilized on filters or supports in glass, silicon or synthetic polymers and these media are used for hybridization.
- the differences between the genomic sequences of the different strains or species can greatly affect the intensity of the hybridization and therefore disturb the interpretation of the results. It may therefore be necessary to have the precise sequence of genes of the strain that one wishes to study.
- the method of detecting genes described later in detail, involving determining the sequence of random fragments of a genome, and organizing them according to the genome sequence of P. luminescens, in particular of P. luminescens TTOl, disclosed in the present invention can be very useful.
- the nucleotide sequences according to the invention can be used in DNA chips to carry out the analysis of mutations. This analysis is based on the constitution of chips capable of analyzing each base of a nucleotide sequence according to the invention. In particular, it will be possible to implement microsequencing techniques on a DNA chip.
- the mutations are detected by extension of immobilized primers hybridizing to the matrix of the sequences analyzed, just in position adjacent to that of the mutated nucleotide sought.
- a single-stranded matrix, RNA or DNA, of the sequences to be analyzed will advantageously be prepared according to conventional methods, from products amplified according to PCR type techniques.
- the single-stranded DNA or RNA matrices thus obtained are then deposited on the DNA chip, under conditions allowing their specific hybridization to the immobilized primers.
- a thermostable polymerase for example Tth or Taq DNA polymerase, specifically extends the 3 'end of the immobilized primer with a labeled nucleotide analog complementary to the nucleotide at the variable site position; for example, thermal cycling is carried out in the presence of fluorescent dideoxyribonucleotides.
- the experimental conditions will be adapted in particular to the chips used, to the immobilized primers, to the polymerases used, and to the chosen labeling system.
- DNA chips according to the invention are also preferred, which also contain at least one nucleotide sequence of a microorganism other than Photorhabdus luminescens, immobilized on the support of said chip.
- the microorganism chosen is from bacteria of the genus Photorhabdus (hereinafter designated as bacteria associated with P. luminescens), or variants of Photorhabdus luminescens TTOl.
- a DNA chip or a filter according to the invention is a very useful element in certain kits or necessary for the detection and / or identification of microorganisms, in particular bacteria belonging to the species Photorhabdus luminescens, also subject of the invention.
- DNA chips or filters according to the invention containing probes or primers specific to Photorhabdus luminescens, are very advantageous elements of kits or necessary for the detection and / or quantification of the expression of photorhabdus genes luminescens.
- the control of gene expression is a critical point for optimizing the growth and yield of a strain, either by allowing the expression of one or more new genes, or by modifying the expression of genes already present in the cell.
- the present invention provides all the naturally active sequences in P. luminescens allowing gene expression. It thus allows the determination of all the sequences expressed in P. luminescens. It also provides a tool for identifying genes whose expression follows a given pattern. To achieve this, the DNA of all or part of the P. luminescens genes can be amplified using primers according to the invention, then fixed to a support such as for example glass or nylon or a DNA chip, in order to build a tool to monitor the expression profile of these genes.
- This tool consisting of this support containing the coding sequences, serves as a hybridization matrix for a mixture of labeled molecules reflecting the messenger RNAs expressed in the cell (in particular the labeled probes according to the invention). By repeating this experience at different times and by combining all of these data by appropriate processing, the expression profiles of all of these genes are then obtained.
- Knowledge of the sequences which follow a given regulatory scheme can also be used to search in a directed manner, for example by homology, for other sequences following globally, but in a slightly different manner the same regulatory scheme.
- each control sequence present upstream of the segments serving as probes and to monitor their activity using an appropriate means such as a reporter gene (luciferase, ⁇ -galactosidase, GFP).
- a reporter gene luciferase, ⁇ -galactosidase, GFP
- the invention also relates to the polypeptides encoded by a nucleotide sequence according to the invention, preferably, by a fragment representative of the preceding sequences and corresponding to an ORF sequence.
- the photorhabdus luminescens TTO1 polypeptides of SEQ ⁇ ) N ° 42 to SEQ ⁇ ) N ° 3855 or coded by SEQ ⁇ ) N ° 5835 to SEQ ⁇ ) N ° 10784 are subject of the invention.
- the invention also includes the polypeptides characterized in that they comprise a polypeptide chosen from: a) a polypeptide of sequence SEQ ⁇ ) N ° 42 to SEQ ⁇ ) N ° 3855 or coded by a sequence SEQ ⁇ ) N ° 5835 to SEQ 11) No. 10784; b) a polypeptide having at least 80%, preferably 85%, 90%, 95% and 98% identity with a polypeptide according to the invention; c) a fragment of at least 5 amino acids of a polypeptide as defined in a); d) a biologically active fragment of a polypeptide as defined in a); and e) a polypeptide as defined in a), b), c) or d) modified.
- the nucleotide sequences coding for the polypeptides described above are also subject of the invention.
- polypeptides in the present description, the terms polypeptides, polypeptide sequences, peptides and proteins are interchangeable.
- polypeptide includes any amino acid sequence used to generate an antibody response. It should be understood that the invention does not relate to polypeptides in natural form, that is to say that they are not taken in their natural environment. On the other hand, it concerns those which could have been isolated or obtained by purification from natural sources, or else obtained by genetic recombination, or by synthesis chemical, and that they can then contain unnatural amino acids as will be described later.
- polypeptide having a certain percentage of identity with another which will also be designated by homologous polypeptide, is intended to denote the polypeptides having, with respect to the natural polypeptides, certain modifications, in particular a deletion, addition or substitution of at least an amino acid, truncation, elongation, chimeric solution and / or mutation, or polypeptides with post-translational modifications.
- homologous polypeptides those whose amino acid sequence has at least 80%, preferably 85%, 90%, 95%, 98% or 99% of identity after optimal alignment with the amino acid sequences are preferred. polypeptides according to the invention.
- one or more consecutive or non-consecutive amino acid (s) may be replaced by “equivalent” amino acids.
- equivalent amino acids is intended here to denote any amino acid capable of being substituted for one of the amino acids of the basic structure without, however, essentially modifying the biological activities of the corresponding peptides as defined by after.
- Leucine can thus be replaced by valine or isoleucine, aspartic acid by glutamine acid, glutamine by asparagine, Targinine by lysine, etc., the reverse substitutions being naturally possible under the same conditions.
- the homologous polypeptides also correspond to the polypeptides encoded by the nucleotide sequences having a certain percentage of identity with the nucleotide sequences of the invention or identical, as defined above and thus include in the present definition polypeptides which are mutated or correspond to inter variations or intra-species, which may exist in Photorhabdus, and which correspond in particular to truncations, substitutions, deletions and / or additions, of at least one amino acid residue. It is understood that the percentage of identity between two polypeptides is calculated in the same way as between two nucleic acid sequences. Thus, the percentage of identity between two polypeptides is calculated after optimal alignment of these two sequences, over a window of maximum homology. To define said maximum homology window, the same algorithms can be used as for the nucleic acid sequences.
- biologically active fragment of a polypeptide according to the invention is intended to denote in particular a fragment of polypeptide, as defined below, having at least one of the biological characteristics of the polypeptides according to the invention, in particular in that it is able to exercise in general even a partial activity, such as for example:
- an enzymatic (metabolic) activity an activity which may be involved in the biosynthesis or biodegradation of organic or inorganic compounds, or preferably a toxic or antibiotic activity, in particular for insects or micro-organisms (bacteria or fungi), or else an activity involved in the biosynthesis of these toxins or antibiotics; such proteins with enzymatic activity may in particular be used in methods of screening and / or selection of compounds capable of modifying this activity, in particular of inhibiting it.
- proteins corresponding in particular to extramembrane proteins could in particular be used as immunogen for the production of antibodies, mono- or polyclonal directed specifically against these extramembrane proteins;
- polypeptide fragment according to the invention is intended to denote a polypeptide comprising at least 5 amino acids, preferably 10, 15, 25, 50, 100 and 150 amino acids.
- Polypeptide fragments can also be prepared by chemical synthesis, from hosts transformed by an expression vector according to the invention which contain a nucleic acid allowing the expression of said fragment, and placed under the control of regulatory elements and / or appropriate expression.
- modified polypeptides mention should be made of the polypeptides in which up to five amino acids can be modified, truncated at the N or C-terminus, or else deleted, or added.
- Chemical synthesis also has the advantage of being able to use unnatural amino acids or non-peptide bonds. Thus, it may be advantageous to use unnatural amino acids, for example in D form, or analogs of amino acids, in particular sulfur forms.
- the invention further relates to the nucleic or peptide sequences according to the present invention with the exception of the nucleic or peptide sequences described in WO 99/54472, WO 99/42589, WO 99/03328, WO 98/08932 and EP 0 823 215.
- the present invention provides the nucleotide sequence of the genome of Photorhabdus luminescens TTOl in the form of 41 contigs or in the form of 9 contigs, as well as certain polypeptide sequences.
- nucleic or peptide sequences characterized by their function can also be identified by their nucleotide and amino acid sequence by referring to Table I.
- the invention relates to a nucleotide sequence according to the invention, characterized in that it codes for a polypeptide of Photorhabdus luminescens TTOl with activity of toxin and / or antibiotic type, or involved in the synthesis of these toxins and / or antibiotics.
- the invention relates to a nucleotide sequence according to the invention, characterized in that it codes for a polypeptide of Photorhabdus luminescens TTOl or one of its fragments involved in the biosynthesis of amino acids.
- the invention relates to a nucleotide sequence according to the invention, characterized in that it codes for a photorhabdus luminescens TTOl polypeptide or one of its fragments involved in the biosynthesis of co factors, prosthetic groups and transporters.
- the invention relates to a nucleotide sequence according to the invention, characterized in that it codes for a cell envelope polypeptide or present on the surface of Photorhabdus luminescens TTOl or for one of its fragments.
- the invention relates to a nucleotide sequence according to the invention, characterized in that it codes for a polypeptide of Photorhabdus luminescens TTOl or one of its fragments involved in the cellular machinery.
- the invention relates to a nucleotide sequence according to the invention, characterized in that it codes for a polypeptide of Photorhabdus luminescens TTOl or one of its fragments involved in central intermediate metabolism.
- the invention relates to a nucleotide sequence according to the invention, characterized in that it codes for a polypeptide of Photorhabdus luminescens TTOl or one of its fragments involved in energy metabolism.
- the invention relates to a nucleotide sequence according to the invention, characterized in that it codes for a polypeptide of Photorhabdus luminescens TTOl or one of its fragments involved in the metabolism of fatty acids and phospholipids.
- the invention relates to a nucleotide sequence according to the invention, characterized in that it codes for a polypeptide of Photorhabdus luminescens TTOl or one of its fragments involved in the metabolism of nucleotides, purines, pyrimidines or nucleosides.
- the invention relates to a nucleotide sequence according to the invention, characterized in that it codes for a polypeptide of Photorhabdus luminescens TTOl or one of its fragments involved in regulatory functions.
- the invention relates to a nucleotide sequence according to the invention, characterized in that it codes for a polypeptide of Photorhabdus luminescens TTOl or one of its fragments involved in the replication process.
- the invention relates to a nucleotide sequence according to the invention, characterized in that it codes for a polypeptide of Photorhabdus luminescens TTOl or one of its fragments involved in the transcription process.
- the invention relates to a nucleotide sequence according to the invention, characterized in that it codes for a polypeptide of Photorhabdus luminescens TTOl or one of its fragments involved in the translation process.
- the invention relates to a nucleotide sequence according to the invention, characterized in that it codes for a photorhabdus luminescens TTOl polypeptide or one of its fragments involved in the protein transport and binding process.
- the invention relates to a nucleotide sequence according to the invention, characterized in that it codes for a polypeptide of Photorhabdus luminescens TTOl or one of its fragments involved in the adaptation to atypical conditions.
- the invention relates to a nucleotide sequence according to the invention, characterized in that it codes for a polypeptide of Photorhabdus luminescens TTOl or one of its fragments in the sensitivity to drugs and the like.
- the invention relates to a nucleotide sequence according to the invention, characterized in that it codes for a photorhabdus polypeptide luminescens TTOl or one of its fragments involved in the functions relating to transposons.
- the invention relates to a nucleotide sequence according to the invention, characterized in that it codes for a polypeptide specific for Photorhabdus luminescens TTOl or one of its fragments.
- the invention relates to a polypeptide according to the invention, characterized in that it is a polypeptide of Photorhabdus luminescens TTOl or one of its activity fragments of toxin type and / or antibiotic, or involved in the synthesis of these toxins and / or antibiotics.
- the invention relates to a polypeptide according to the invention, characterized in that it is a polypeptide of Photorhabdus luminescens TTOl or one of its fragments involved in the biosynthesis of acids amines.
- the invention relates to a polypeptide according to the invention, characterized in that it is a polypeptide of Photorhabdus luminescens TTOl or one of its fragments involved in the biosynthesis of cofactors , prosthetic groups and carriers.
- the invention relates to a polypeptide according to the invention, characterized in that it is a cell envelope or surface polypeptide of Photorhabdus luminescens TTOl or one of its fragments.
- the invention relates to a polypeptide according to the invention, characterized in that it is a polypeptide of Photorhabdus luminescens TTOl or one of its fragments involved in cellular machinery.
- the invention relates to a polypeptide according to the invention, characterized in that it is a polypeptide of Photorhabdus luminescens TTOl or one of its fragments involved in central intermediate metabolism .
- the invention relates to a polypeptide according to the invention, characterized in that it is a polypeptide of Photorhabdus luminescens TTOl or one of its fragments involved in energy metabolism.
- the invention relates to a polypeptide according to the invention, characterized in that it is a polypeptide of Photorhabdus luminescens TTOl or one of its fragments involved in the metabolism of acids fatty and phospholipids.
- the invention relates to a polypeptide according to the invention, characterized in that it is a polypeptide of Photorhabdus luminescens TTOl or one of its fragments involved in the metabolism of nucleotides , purines, pyrimidines or nucleosides.
- the invention relates to a polypeptide according to the invention, characterized in that it is a polypeptide of Photorhabdus luminescens TTOl or one of its fragments involved in the regulatory functions .
- the invention relates to a polypeptide according to the invention, characterized in that it is a polypeptide of Photorhabdus luminescens TTOl or one of its fragments involved in the replication process .
- the invention relates to a polypeptide according to the invention, characterized in that it is a polypeptide of Photorhabdus luminescens TTOl or one of its fragments involved in the transcription process .
- the invention relates to a polypeptide according to the invention, characterized in that it is a polypeptide of Photorhabdus luminescens TTOl or one of its fragments involved in the translation process .
- the invention relates to a polypeptide according to the invention, characterized in that it is a polypeptide of Photorhabdus luminescens TTOl or one of its fragments involved in the transport process and protein binding.
- the invention relates to a polypeptide according to the invention, characterized in that it is a polypeptide of Photorhabdus luminescens TTOl or one of its fragments involved in the adaptation to atypical conditions.
- the invention relates to a polypeptide according to the invention, characterized in that it is a polypeptide of Photorhabdus luminescens TTOl or a fragment thereof in sensitivity to drugs and the like.
- the invention relates to a polypeptide according to the invention, characterized in that it is a polypeptide of Photorhabdus luminescens TTOl or one of its fragments involved in the functions relating to transposons.
- the invention relates to a polypeptide according to the invention, characterized in that it is a polypeptide specific for Photorhabdus luminescens TTOl or one of its fragments.
- the invention also relates to the operons involved in the synthesis of antibiotics and / or toxins.
- Table I provides the list of certain polypeptides according to the invention, as well as their location in the contigs represented by SEQ 1) No. 1 to SEQ 1) No. 41, and the analogies observed after comparison in the databases.
- Table ⁇ provides the list of certain polypeptides according to the invention, as well as their location in the contigs represented by SEQ ⁇ ) N ° 5826 to SEQ ⁇ ) N ° 5834, and the analogies observed after comparison in the databases.
- contig 1 to 9 are identified by the sequences SEQ ⁇ ) N ° 5826 to SEQ ⁇ ) N ° 5834.
- the subject of the invention is also the polypeptides whose functions annotated with table I, last column, or whose functions annotated in table ⁇ , penultimate column, correspond to toxin and / or antibiotic type activities, or to polypeptides involved in the synthesis of these toxins and / or antibiotics, preferably polypeptides chosen from: a) the polypeptides of sequence SEQ ⁇ ) N ° 61, SEQ ⁇ ) N ° 62, SEQ ⁇ ) N ° 67, SEQ ⁇ ) N ° 171, SEQ ⁇ ) N ° 221, SEQ ⁇ ) N ° 268 , SEQ ⁇ ) N ° 288, SEQ ⁇ ) N ° 380, SEQ ⁇ ) N ° 426, SEQ ⁇ ) N ° 438, SEQ ⁇ ) N ° 448, SEQ ⁇ ) N ° 453, SEQ ⁇ ) N ° 455, SEQ ⁇ ) N ° 456, SEQ ⁇ ) N °
- a subject of the present invention is also the nucleotide and / or polypeptide sequences according to the invention, characterized in that said sequences are recorded on a recording medium the shape and nature of which facilitate reading, analysis and / or the exploitation of said sequence (s).
- These supports can also contain other information extracted from the present invention, in particular analogies with already known sequences, and / or information concerning the nucleotide and / or polypeptide sequences of a plant cell, of an animal or a micro-organism other than P.
- luminescens in particular a cell or micro-organism sensitive to a toxin or an antibiotic produced by P. luminescens, a bacterium of the genus Photorhabdus, or a variant of P.
- luminescens this in order to facilitate comparative analysis and exploitation of the results obtained.
- recording media particular preference is given to media readable by a computer, such as magnetic, optical, electrical or hybrid media, in particular computer floppy disks, CD-ROMs, computer servers.
- Such recording media are also subject of the invention.
- the recording media according to the invention are very useful for the choice of primers or nucleotide probes for the determination of genes in Photorhabdus luminescens TTOl or strains close to this organism.
- the use of these supports for the study of the genetic polymorphism of strains close to Photorhabdus luminescens TTOl, in particular by the determination of the regions of collinearity is very useful insofar as these supports provide not only the nucleotide sequence of the genome of Photorhabdus luminescens TTOl, but also the genomic organization in said sequence.
- sequence comparison software such as software
- the invention also relates to the cloning and / or expression vectors, which contain a nucleotide sequence according to the invention.
- the vectors according to the invention preferably comprise elements which allow the expression and / or the secretion of the nucleotide sequences in a determined host cell.
- the vector must then include a promoter, translation initiation and termination signals, as well as suitable regions for transcription regulation. It must be able to be maintained stably in the host cell and may possibly have specific signals which specify the secretion of the translated protein. These various elements are chosen and optimized by a person skilled in the art according to the cell host used. To this end, the nucleotide sequences according to the invention can be inserted into vectors with autonomous replication within the chosen host, or can be vectors integrating with the chosen host.
- vectors are prepared by methods commonly used by those skilled in the art, and the resulting clones can be introduced into an appropriate host by standard methods, such as lipofection, electroporation, heat shock, or chemical methods .
- the vectors according to the invention are for example vectors of plasmid or viral origin. They are useful for transforming host cells in order to clone or express the nucleotide sequences according to the invention.
- the cloning and / or expression vectors according to the invention are also preferred, characterized in that they contain a nucleotide sequence chosen from the sequences SEQ ⁇ ) N ° 3856 to SEQ ⁇ ) N ° 5825 , SEQ ⁇ ) N ° 5835 to SEQ ⁇ ) N ° 10784 or their fragment derived from the genome of P. luminescens, in particular the sequences coding for the polypeptides with toxin activity, antibiotics or involved in these activities, in particular those mentioned above whose functions annotated in table I below correspond to these activities.
- the invention also includes host cells transformed with a vector according to the invention.
- the cell host can be chosen from prokaryotic or eukaryotic systems, for example bacterial cells but also yeast cells or animal cells, in particular mammalian cells. You can also use insect cells or plant cells.
- the preferred host cells according to the invention are in particular prokaryotic cells, preferably bacteria belonging to the genus Photorhabdus or to the species Photorhabdus luminescens, more particularly Photorhabdus luminescens TTOl.
- the invention also relates to plants and animals, except humans, which comprise a transformed cell according to the invention.
- the cells transformed according to the invention can be used in processes for the preparation of recombinant polypeptides according to the invention.
- the methods for preparing a polypeptide according to the invention in recombinant form characterized in that they use a vector and / or a cell transformed with a vector according to the invention are themselves included in the present invention.
- a cell transformed with a vector according to the invention is cultivated under conditions which allow the expression of said polypeptide and said recombinant peptide is recovered.
- the cell host can be chosen from prokaryotic or eukaryotic systems.
- a vector according to the invention carrying such a sequence can therefore be advantageously used for the production of recombinant proteins, intended to be secreted. Indeed, the purification of these recombinant proteins of interest will be facilitated by the fact that they are present in the supernatant of the cell culture rather than inside the host cells.
- the polypeptides according to the invention can also be prepared by chemical synthesis. Such a preparation process is also an object of the invention.
- a person skilled in the art knows the chemical synthesis processes, for example the techniques implementing solid phases (see in particular Steward et al., 1984, Solid phase peptides synthesis, Pierce Chem. Company, Rockford, 111, 2nd ed., (1984)) or techniques using partial solid phases, by condensation of fragments or by synthesis in conventional solution.
- the polypeptides obtained by chemical synthesis and possibly comprising corresponding non-natural amino acids are also included in the invention.
- hybrid polypeptides according to the invention are very useful for obtaining monoclonal or polyclonal antibodies capable of specifically recognizing the polypeptides according to the invention.
- polyclonal or monoclonal antibodies can be obtained by standard methods well known to those skilled in the art, after immunization of a mammal using these polypeptides (or their corresponding nucleic acid) or for example according to the conventional method of hybridoma culture described by Kohler and Milstein (1975, Nature, 256, 495) for monoclonal antibodies.
- Such monoclonal or polyclonal antibodies, their fragments, or chimeric antibodies, recognizing the polypeptides according to the invention, are also objects of the invention.
- the antibodies according to the invention are, for example, chimeric antibodies, humanized antibodies, Fab fragments, or F (ab ') 2 . They can also be in the form of immunoconjugates or labeled antibodies in order to obtain a detectable and / or quantifiable signal.
- the antibodies according to the invention can be used in a method for the detection and / or identification of bacteria belonging to the genus Photorhabdus and / or to the species Photorhabdus luminescen in a biological sample, characterized in that it comprises the following steps: a) bringing the biological sample into contact with an antibody according to the invention; b) highlighting of the antigen-antibody complex possibly formed.
- the antibodies according to the present invention are also usable in order to detect an expression of a gene of Photorhabdus luminescens TTOl. Indeed, the presence of the expression product of a gene recognized by an antibody specific for said expression product can be detected by the presence of an antigen-antibody complex formed after contacting the strain of Photorhabdus luminescens TTOl with an antibody according to the invention.
- the bacterial strain used may have been "prepared", that is to say centrifuged, lysed, placed in a reagent suitable for constituting the medium suitable for the immunological reaction.
- a method of detecting expression in the gene, corresponding to a Western blot which can be carried out after an electrophoresis on polyacrylamide gel of a lysate of the bacterial strain, is preferred, in the presence or in the absence of reducing conditions (SDS- PAGE).
- SDS- PAGE reducing conditions
- the present invention also comprises the kits or kits necessary for the implementation of a method as described (for detecting the expression of a gene of Photorhabdus luminescens TTOl, or for the detection and / or identification of bacteria belonging to the species Photorhabdus luminescens), comprising the following elements: a) a polyclonal or monoclonal antibody according to the invention; b) optionally, the reagents for constituting the medium suitable for the immunological reaction; c) optionally, the reagents allowing the detection of the antigen-antibody complexes produced by the immunological reaction.
- polypeptides and antibodies according to the invention can advantageously be immobilized on a support, in particular a protein chip.
- a protein chip is an object of the invention, and may also contain at least one polypeptide from a microorganism other than Photorhabdus luminescens or an antibody directed against a compound of a microorganism other than Photorhabdus luminescens.
- the protein chips or high density filters containing proteins according to the invention can be constructed in the same way as the DNA chips according to the invention.
- the latter method is preferable, when it is desired to attach proteins of large size to the support, these proteins being advantageously prepared by genetic engineering.
- the protein chips according to the invention can advantageously be used in kits or necessary for the detection and / or identification of bacteria associated with the species Photorhabdus luminescens or with a microorganism, or more generally in kits or necessary for the detection and / or identification of microorganisms.
- the polypeptides according to the invention are fixed on the DNA chips, one searches for the presence of antibodies in the samples tested, the fixing of a antibody according to the invention on the support of the protein chip allowing the identification of the protein of which said antibody is specific.
- an antibody according to the invention is fixed on the support of the protein chip, and the presence of the corresponding antigen, specific for Photorhabdus luminescens, is detected.
- a protein chip described above can be used for the detection of gene products, to establish an expression profile of said genes, in addition to a DNA chip according to the invention.
- the protein chips according to the invention are also extremely useful for proteomics experiments, which studies the interactions between the different proteins of a plant cell, an animal, such as an insect, or a micro- organism other than P. luminescens.
- the invention also comprises a protein chip according to the invention, characterized in that it also contains at least one polypeptide from a plant cell, from an animal or from a microorganism other than P luminescens, immobilized on the support of said chip, preferably said cell or other microorganism is chosen from a cell or microorganism sensitive to a toxin or an antibiotic produced by P. luminescens.
- peptides representative of the various proteins of an organism are fixed on a support. Then, said support is brought into contact with labeled proteins, and after an optional rinsing step, interactions between said labeled proteins and the peptides fixed on the protein chip are detected.
- protein chips comprising a polypeptide sequence according to the invention or an antibody according to the invention are subject of the invention, as well as the kits or kits containing them.
- the present invention also covers a method for detecting and / or identifying bacteria belonging to the species Photorhabdus luminescens in a biological sample, which implements a nucleotide sequence according to the invention.
- biological sample relates in the present invention to samples taken from a living organism (in particular blood, tissues, organs or the like taken from a mammal) or a sample containing biological material, that is, DNA or RNA.
- a biological sample also includes food compositions containing bacteria (for example cheeses, dairy products), but also food compositions containing yeasts (beers, breads) or others.
- the term biological sample also relates to bacteria isolated from these samples or food compositions.
- the detection and / or identification process using the nucleotide sequences according to the invention can be of various nature.
- a method is preferred comprising the following steps: a) optionally, isolation of the DNA from the biological sample to be analyzed, or obtaining a cDNA from the RNA of the biological sample; b) specific amplification of the DNA of bacteria belonging to the species Photorhabdus luminescens using at least one primer according to the invention; c) highlighting of the amplification products.
- This process is based on specific amplification of DNA, in particular by an amplification chain reaction.
- a method is also preferred comprising the following steps: a) bringing a nucleotide probe according to the invention into contact with a biological sample, the nucleic acid contained in the biological sample having, if necessary, previously been made accessible to hybridization, under conditions allowing hybridization of the probe to the nucleic acid of a bacterium belonging to the species Photorhabdus luminescens; b) demonstration of the hybrid possibly formed between the nucleotide probe and the DNA of the biological sample.
- Such a method should not be limited to the detection of the presence of the DNA contained in the biological sample to be tested, it can also be implemented to detect the RNA contained in said sample.
- This process includes in particular the Southern and Northern blot.
- Another preferred method according to the invention comprises the following steps: a) bringing a nucleotide probe immobilized on a support according to the invention into contact with a biological sample, the nucleic acid of the sample, having, where appropriate , been previously made accessible to hybridization, under conditions allowing hybridization of the probe to the nucleic acid of a bacterium belonging to the species Photorhabdus luminescens; b) bringing the hybrid formed into contact between the nucleotide probe immobilized on a support and the nucleic acid contained in the biological sample, where appropriate after elimination of the DNA from the biological sample which has not hybridized with the probe, with a labeled nucleotide probe according to the invention; c) highlighting of the new hybrid formed in step b).
- This method is advantageously used with a DNA chip according to the invention, the desired nucleic acid hybridizing with a probe present on the surface of said chip, and being detected by the use of a labeled probe.
- This method is advantageously implemented by combining a prior step of amplification of the DNA or of the complementary DNA optionally obtained by reverse transcription, using primers according to the invention.
- kits or kits for the detection and / or identification of bacteria belonging to the species Photorhabdus luminescens characterized in that it comprises the following elements: a) a nucleotide probe according to the invention ; b) optionally, the reagents necessary for carrying out a hybridization reaction; c) optionally, at least one primer according to the invention as well as the reagents necessary for a DNA amplification reaction.
- kits or kits for the detection and / or identification of bacteria belonging to the species Photorhabdus luminescens TTOl characterized in that it comprises the following elements: a) a nucleotide probe, called capture probe according to the invention; b) an oligonucleotide probe, called the revelation probe, according to the invention; c) optionally, at least one primer according to the invention as well as the reagents necessary for a DNA amplification reaction.
- kits or kits for the detection and / or identification of bacteria belonging to the Photorhabdus luminescens species characterized in that they comprise the following elements: a) at least one primer or probe according to the invention; b) optionally, the reagents necessary to carry out a DNA amplification reaction; c) optionally, a component making it possible to verify the sequence of the amplified fragment, more particularly an oligonucleotide probe according to the invention, are also objects of the present invention.
- said primers and / or probes and / or polypeptides and / or antibodies according to the present invention used in the methods and / or kits or necessary according to the present invention are chosen from primers and / or probes and / or polypeptides and / or specific antibodies for the species Photorhabdus luminescens.
- these elements are chosen from the nucleotide sequences coding for a secreted protein, from secreted polypeptides, or from antibodies directed against secreted polypeptides of Photorhabdus luminescens.
- the subject of the present invention is also the strains of Photorhabdus luminescens TTOl containing one or more mutation (s) in a nucleotide sequence according to the invention, in particular an ORF sequence, or their regulatory elements (in particular promoters).
- the strains of Photorhabdus luminescens TTOl having one or more mutation (s) in the nucleotide sequences coding for polypeptides preferably with activity of toxin or antibiotic type, or involved in their biosynthesis, or alternatively under a another aspect involved in cellular machinery, in particular secretion, central intermediate metabolism, energy metabolism, the processes of amino acid synthesis, transcription and translation, synthesis of polypeptides.
- Said mutations can lead to inactivation of the gene, or in particular when they are located in the regulatory elements of said gene, to overexpression of the latter.
- the strains of Photorhabdus luminescens TTOl having one or more mutation (s) can be used to validate the wild gene function of Photorhabdus luminescens.
- the invention further relates to the use of a nucleotide sequence according to the invention, a polypeptide according to the invention, an antibody according to the invention, and / or a cell according to the invention, for the selection of an organic or inorganic compound capable of modulating, regulating, inducing or inhibiting the expression of genes of a plant or animal cell, or of a microorganism other than P. luminescens, of which, by For example, we want to modify the resistance or the sensitivity to at least one toxin or antibiotic produced by P. luminescens.
- the invention also includes a method of selecting compounds capable of binding to a polypeptide or a fragment thereof according to the invention, capable of binding to a nucleotide sequence according to the invention, or capable of recognizing an antibody according to invention, and / or capable of modulating, regulating, inducing or inhibiting gene expression, and / or modifying the growth or cellular replication of eukaryotic or prokaryotic cells, or capable of inducing, inhibit or increase in an animal or plant organism resistance or sensitivity to at least one toxin or antibiotic produced by P.
- luminescens said method comprising the following steps: a) bringing said compound into contact with said polypeptide, said nucleotide sequence and / or with a cell transformed according to the invention; b) determining the capacity of said compound to bind with said polypeptide or said nucleotide sequence, or to modulate, regulate, induce or inhibit the expression of genes, or to modulate cell growth or replication, or to induce, inhibit or increase in an animal or plant organism resistance or sensitivity to at least one toxin or antibiotic produced by P. luminescens.
- the cells transformed according to the invention can advantageously serve as a model and be used in methods for studying, identifying and / or selecting compounds capable of being responsible for the resistance or the sensitivity to at least one toxin or antibiotic produced by P luminescens.
- the compounds which can be selected can be organic compounds such as polypeptides or carbohydrates or any other organic or inorganic compounds already known, or new organic compounds produced from molecular modeling techniques and obtained by chemical or biochemical synthesis. , these techniques being known to those skilled in the art.
- the invention relates to compounds capable of being selected by a selection method according to the invention.
- the invention also relates to a composition, in particular pesticide or pharmaceutical, comprising a compound chosen from the following compounds: a) a nucleotide sequence according to the invention; b) a polypeptide according to the invention; c) a vector according to the invention; d) an antibody according to the invention; and e) a compound capable of being selected by a selection method according to the invention, optionally in combination with a pharmaceutically acceptable vehicle.
- the invention also relates to a pharmaceutical composition according to the invention for the prevention or treatment of an infection by a microorganism, such as a bacteria or a fungus, sensitive to at least one toxin or antibiotic produced by P. luminescens.
- a microorganism such as a bacteria or a fungus
- the invention also relates to a pesticidal composition, in particular against insects, bacteria and / or fungi, according to the invention, for the prevention or treatment of plants infected by animals, such as insects, or by a microorganism, such as '' a bacterium or a fungus, sensitive to at least one toxin or antibiotic produced by P. luminescens.
- the invention also includes the use of a transformed cell according to the invention, for the preparation of a toxin or an antibiotic produced by P. luminescens.
- pharmaceutically acceptable vehicle is intended to denote a compound or a combination of compounds entering into a pharmaceutical composition which does not cause side reactions and which allows for example the facilitation of the administration of the active compound, the increase in its lifespan and / or of its effectiveness in the organism, the increase of its solubility in solution or the improvement of its conservation.
- pharmaceutically acceptable vehicles are well known and will be adapted by those skilled in the art depending on the nature and the mode of administration of the active compound chosen.
- these pharmaceutical compounds will be administered by the systemic route, in particular by the intravenous route, by the intramuscular, intradermal or subcutaneous route, or by the oral route.
- dosages and dosage forms can be determined according to the criteria generally taken into account in establishing a treatment adapted to a patient such as for example the patient's age or body weight, the severity of his general condition, tolerance to treatment and side effects observed.
- the invention comprises the use of a composition according to the invention, for the preparation of a medicament intended for the prevention or the treatment of an infection by a microorganism, such as a bacterium or a fungus , sensitive to at least one toxin or antibiotic produced by P. luminescens.
- the present invention also relates to a genomic DNA library of a bacterium of the genus Photorhabdus, preferably, Photorhabdus luminescens, preferably the strain TTOl.
- the genomic DNA libraries described in the present invention in particular the BAC library deposited at the CNCM on May 12, 2000 under the number 1-2478 and which covers the genome of Photorhabdus luminescens TTOl.
- the invention also relates to a method of identifying at least one nucleotide sequence of P. luminescens not present in the genome of another species of bacteria, in particular pathogenic, and / or of identifying at least one nucleotide sequence of a genome of a bacterium, in particular pathogenic, of a species other than P. luminescens and not present in the genome of P. luminescens, characterized in that it comprises the following stages: a) the nucleotide sequences are aligned of P.
- luminescens according to the invention or contained in a genomic library according to the invention, with the genomic sequence of the other species of bacteria, or one of its fragments; and b) the data obtained by this alignment are processed to isolate and identify the said sequence or sequences only present in one or the other genome.
- a method also called “subtractive genomics” can be used here to identify a sequence responsible for the pathogenicity of a bacterium, such as a gram negative bacterium, of which the non-pathogenic P. luminescens bacterium can serve as a model for comparison.
- the present invention thus relates to methods for the isolation of a polynucleotide of interest present in a strain of Photorhabdus and absent in another strain or species, which uses at least one DNA library based for example on a plasmid pcDNA2. 1 containing the Photorhabdus genome.
- the method according to the invention for the isolation of a polynucleotide of interest can comprise the following steps: a) isolating at least one polynucleotide contained in a clone of the original DNA library of Photorhabdus; b) isolate:
- At least one genomic polynucleotide or cDNA of a bacterium said bacterium belonging to a strain or species different from the Photorhabdus strain used for the construction of the DNA library of step a) or, alternatively,
- step b at least one polynucleotide contained in a clone of a DNA bank prepared from the genome of a bacterium belonging to a strain or species different from the Photorhabdus strain used for the construction of the DNA bank of step a) and hybridize the polynucleotide of step a) to the polynucleotide of step b); c) selecting the polynucleotides of step a) which have not formed a hybridization complex with the polynucleotides of step b); d) characterize the selected polynucleotide.
- the polynucleotide of step a) can be prepared by digestion of at least one recombinant clone with an appropriate restriction enzyme, and optionally, the amplification of the resulting polynucleotide insert.
- the method of the invention allows a person skilled in the art to carry out comparative genomic studies between a bacterium of the genus Photorhabdus, and for example between a strain or pathogenic species.
- the present invention also relates to the use of the nucleic sequences or polypeptides according to the present invention:
- bio-pesticides in particular entomotoxins, antibiotics, antifungals or cytotoxins
- the present invention also relates to the use of the polypeptides according to the present invention for the screening of compounds capable of modulating the activity of these polypeptides, in particular the polypeptides with enzymatic activity.
- Other characteristics and advantages of the invention appear in the following examples:
- Example 1 Materials and methods The genome sequencing strategy for Photorhabdus luminescens strain TTOl is based on randomized shot-gun sequencing. The first step in this work consisted in cloning the genomic DNA of the bacterium Photorhabdus luminescens into different vectors (plasmids and BAC). Genomic DNA libraries of Photorhabdus luminescens used.
- a dry pellet of genomic DNA from the TTOl strain prepared on 10/30/98 was taken up in 200 ⁇ l of TE 10: 1 and then dissolved for 30 min at 65 ° C. Its concentration has been estimated at 0.15 ⁇ g / ⁇ l.
- DNA precipitation This DNA was then precipitated with sodium acetate (2 ml of DNA + 0.2 ml of 3M Na acetate pH 5.2 + 5 ml of absolute ethanol; 2 h at -20 ° C; centrifuged at 30 min at 14,000 rpm, 4 ° C then redissolved in 100 ⁇ l of water.
- DNA fragments of the expected size 500 bpd to 3 kb were visualized.
- This DNA was then precipitated overnight at -20 ° C with sodium acetate (1/10 of the volume of Na acetate and 2.5 volume of absolute ethanol), centrifuged and the DNA pellet obtained was air-dried and redissolved in 30 ⁇ l of water.
- the region of interest (between 1 and 3 Kb) was cut into four fragments.
- the genomic DNA bank obtained in step 10 was integrated into the ultra-competent XL2 Blue cells (Stratagene) according to the conditions recommended by the manufacturer.
- the partial filling technique (PARTIAL FTLL-IN), developed in the laboratory, allowed us to build a genomic DNA bank of the TTOl strain of the bacterium Photorhabdus luminescens cloned in the plasmid pSYX34 (size of the inserts approximately 10 Kb) .
- the PARTIAL F ⁇ X-IN was carried out in the presence of the deoxynucleotides dCTP and dTTP.
- Plasmid pSYX34 was prepared, by carrying out in parallel two midipreps, KIT QIAGEN according to the conditions recommended by the manufacturer.
- Chloroform extraction makes it possible to stop enzymatic digestion, and to eliminate all protein traces.
- nucleotide C 100 mM
- TRIS 10 mM
- the nucleotides are thus diluted 1/10, for a concentration of 10 mM.
- a second 1/10 dilution in 10 mM TRIS buffer will be made to have a concentration of 1 M.
- the nucleotides are diluted to 1/20 (2.5 ⁇ l in 50 ⁇ l), a final concentration thus obtained of 50 ⁇ M in nucleotides.
- a dry pellet of genomic DNA of the TTOl strain was taken up in 200 ⁇ l of TE 10: 1 and then dissolved for 30 min at 65 ° C. Its concentration has been estimated at 0.15 ⁇ g / ⁇ l. 2) Partial digestion of genomic DNA by the restriction enzyme Sau3A
- the chloroform extraction allows us to stop the enzymatic digestion, and to eliminate all protein traces.
- Vortex centrifuge 1 min at 1000 rpm. Recover the aqueous phase, upper phase, comprising chromosomal DNA.
- nucleotides G 100 mM
- TRIS 10 mM pH - 7.5.
- the nucleotides are thus diluted to 1/10, there is a concentration of 10 mM.
- a second 1/10 dilution in HO will be carried out, so there is a concentration of 1 mM.
- the chloroform extraction makes it possible to stop the enzymatic digestion, and to eliminate all protein traces.
- Chloroform extraction eliminates all protein traces.
- Vortex centrifuge 1 min at 1000 rpm.
- the genomic DNA bank obtained in the previous step was integrated into the XL10 Gold Kanr ultra-competent cells (Stratagene) according to the conditions recommended by the manufacturer.
- the agarose pieces are balanced twice in 300 ⁇ l of Hind III digestion buffer (1x) (Boehringer or Biolabs) for 30 minutes at room temperature;
- molten agarose / DNA solution is balanced for 15 minutes at 45 ° C; - gelase (Epicenter Technologies) is added, at a rate of 1 U per 100 ⁇ l of gel strip (do not add digestion buffer which causes certain problems at the time of ligation);
- the ligation is carried out in 50 ⁇ l of a solution containing pBeloBAC ⁇ (2 ⁇ l), of T4 ligase (1 ⁇ l at 1:10), a T4 lOx buffer (5 ⁇ l), and the DNA / agarose solution
- the ligation medium is heated for 15 minutes at 65 ° C;
- the ligation medium is dyalized against a Tris-EDTA buffer using Millipore membranes with a pore size VS 0.025 mM; - 1 or 2 ⁇ l of the ligation solution are introduced by electroporation into the E. coli DH10B cells (Gibco BRL) using electroporation cuvettes with a width of 2 mm with the following settings 2.5 kV, 25 ⁇ F and 200 ⁇ ; - After electroporation, the cells are resuspended in 600 ⁇ l of SOC or NYZ medium and then incubated for 45 minutes at 37 ° C with shaking;
- Plasmid DNA extraction was carried out by the alkaline lysis technique in 24-well plates.
- the sequencing of the clone inserts was carried out by the KIT PE Big Dye according to the conditions recommended by the manufacturer using the specific oligonucleotides of each vector.
- the reactions are then introduced into the thermal cycler in order to undergo 35 cycles composed of the following three stages:
- Precipitation is then carried out with 76% ethanol for 20 minutes at room temperature.
- the plates are then centrifuged 35 minutes at 2200 g and then drained on absorbent paper and then centrifuged inverted on absorbent paper for 1 minute at 500 g so as to leave no trace of ethanol.
- the DNA pellets are then: - either taken up in a solution of formamide-EDTA-blue dextran, then denatured for 2 minutes at 96 ° C.
- the plates are then immediately put in ice, an aliquot then being deposited on acrylamide gel of an automatic sequencer PE-377,
- genomic DNA sequences were assembled contiguously by the PHRED-PHRAP software and visualized by the CONSED software. Analysis and annotation The contigs were first analyzed and annotated automatically by the GMPTB software.
- Example 2 Genes of Interest The various characteristics linked to the lifestyle of Photorhabdus luminescens and reported in the literature (Forst et al., 1997; Hu et al., 1998, etc.), led to research in the genome of this bacterium the presence of genes involved in the biosynthesis of antibiotics and toxins. Antibiotic biosynthesis operons The search for peptide-synthesized hases was undertaken in silico. To do this, we first used the different motifs classically described in the literature (Stachelhaus & Marahiel, 1995, FEMS Microbiology Letters 125: 3- 14) as a probe in order to identify by sequence homology in the genome of Photorhabdus luminescens, genes likely to be involved in the biosynthesis of antibiotics.
- His- HHILxDGW Racemization peptide module (optional) His- HfflLxDGW A - AYxTExND ⁇ XTAxG
- Photorhabdus luminescens W-14 insecticidal activity consists of at least two similar but distinct protems. Purification and characterization of toxin A and toxin B. J Biol Chem., 274: 9836-42.
- Photorhabdus luminescens strain TTOl clones in the vector pBelo BAC ⁇ (Kim et al, Genomics, 34, 213, 1996) at the Hind III site.
- the average size of the inserts is 60 kb.
- the protein bank used is constituted by the non-redundant fusion of these banks, such as the Genpept bank (automatic translation of GenBank and NCBI).
- the BLAST software package (public domain, Altschul et al., 1990) was used to search for homologies between a sequence and protein or nucleic databases.
- the significance thresholds used depend on the length and complexity of the region tested as well as the size of the reference bank. They were adjusted and adapted to each analysis.
- the results of search for homologies between a sequence according to the invention and protein or nucleic databases are presented and summarized in Table I and III below.
- nucleic acid sequences of sequence SEQ ⁇ ) N ° 5835 to SEQ ⁇ ) N ° 10784 can be easily identified by their start (column “CONTIG”, “from”) and end position (column "CONTIG””to”) on each of the legend contig sequences in table ⁇ :
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0101659 | 2001-02-07 | ||
FR0101659 | 2001-02-07 | ||
PCT/IB2002/003040 WO2002094867A2 (fr) | 2001-02-07 | 2002-02-07 | Sequence du genome de photorhabdus luminescens souche tto1 et utilisations |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1379549A2 true EP1379549A2 (de) | 2004-01-14 |
Family
ID=8859730
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20020751498 Withdrawn EP1379549A2 (de) | 2001-02-07 | 2002-02-07 | Genomsequenz des photorhabdus luminescens stamms tt01 und verwendungen |
Country Status (6)
Country | Link |
---|---|
US (1) | US20070020625A1 (de) |
EP (1) | EP1379549A2 (de) |
KR (1) | KR20030085528A (de) |
AU (1) | AU2002339119A1 (de) |
CA (1) | CA2434323A1 (de) |
WO (1) | WO2002094867A2 (de) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO20026285D0 (no) * | 2002-12-30 | 2002-12-30 | Amersham Health As | Nye peptider |
US7071386B2 (en) | 2003-01-21 | 2006-07-04 | Dow Agrosciences Llc | Xenorhabdus TC gene for pest control |
AR043328A1 (es) | 2003-01-21 | 2005-07-27 | Dow Agrosciences Llc | Metodo para la inhibicion de insectos |
ATE486087T1 (de) * | 2003-11-06 | 2010-11-15 | Danisco Us Inc | Fgf-5-bindende und geträgerte peptide |
AR048074A1 (es) | 2004-03-02 | 2006-03-29 | Dow Agrosciences Llc | Proteinas de fusion de complejos de toxinas insecticidas |
AU2006227165B2 (en) | 2005-03-18 | 2011-11-10 | Microbia, Inc. | Production of carotenoids in oleaginous yeast and fungi |
WO2006123157A2 (en) * | 2005-05-18 | 2006-11-23 | University Of Bath | Nematistatic protein |
US8691555B2 (en) | 2006-09-28 | 2014-04-08 | Dsm Ip Assests B.V. | Production of carotenoids in oleaginous yeast and fungi |
EP2234632B1 (de) * | 2008-01-10 | 2014-10-29 | Endocrine Pharmaceuticals Limited | Proteinöse verbindungen |
AT506535B1 (de) * | 2008-02-22 | 2010-04-15 | Affiris Forschungs & Entwicklungs Gmbh | Vaccine enthaltend alpha-synuclein-mimotope auf basis von peptiden |
WO2009129558A1 (en) * | 2008-04-24 | 2009-10-29 | Newsouth Innovations Pty Limited | Cyanobacteria saxitoxin gene cluster and detection of cyanotoxic organisms |
US9090882B2 (en) | 2008-06-30 | 2015-07-28 | Monsanto Technology Llc | Compositions and methods for enhanced amino acid levels in plants conferred by lysine and/or threonine feedback insensitive aspartate kinase proteins |
UA112050C2 (uk) * | 2008-08-04 | 2016-07-25 | БАЄР ХЕЛСКЕР ЛЛСі | Терапевтична композиція, що містить моноклональне антитіло проти інгібітора шляху тканинного фактора (tfpi) |
US9085798B2 (en) | 2009-04-30 | 2015-07-21 | Prognosys Biosciences, Inc. | Nucleic acid constructs and methods of use |
EP2277989A1 (de) | 2009-07-24 | 2011-01-26 | Technische Universiteit Delft | Fermentative glycerolfreie Ethanolherstellung |
SG10201903166PA (en) | 2010-03-01 | 2019-05-30 | Bayer Healthcare Llc | Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi) |
US20190300945A1 (en) | 2010-04-05 | 2019-10-03 | Prognosys Biosciences, Inc. | Spatially Encoded Biological Assays |
US10787701B2 (en) | 2010-04-05 | 2020-09-29 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
JP5893607B2 (ja) | 2010-04-05 | 2016-03-23 | プログノシス バイオサイエンシズ インコーポレイテッドPrognosys Biosciences,Inc. | 空間コード化生物学的アッセイ |
WO2012139110A2 (en) * | 2011-04-08 | 2012-10-11 | Prognosys Biosciences, Inc. | Peptide constructs and assay systems |
GB201106254D0 (en) | 2011-04-13 | 2011-05-25 | Frisen Jonas | Method and product |
WO2013065302A1 (ja) * | 2011-11-01 | 2013-05-10 | 独立行政法人産業技術総合研究所 | 未分化細胞検出方法及び複合糖質検出方法 |
KR101246707B1 (ko) * | 2012-08-01 | 2013-03-25 | ㈜엠알이노베이션 | 포토랍두스 템프라타 템프라타 균주를 포함하는 뿌리혹선충 방제용 조성물 |
CN111233978A (zh) | 2013-03-15 | 2020-06-05 | 普罗格诺西斯生物科学公司 | 用于检测肽/mhc/tcr结合的方法 |
WO2014210223A1 (en) | 2013-06-25 | 2014-12-31 | Prognosys Biosciences, Inc. | Spatially encoded biological assays using a microfluidic device |
WO2015070037A2 (en) | 2013-11-08 | 2015-05-14 | Prognosys Biosciences, Inc. | Polynucleotide conjugates and methods for analyte detection |
ES2935860T3 (es) | 2015-04-10 | 2023-03-13 | Spatial Transcriptomics Ab | Análisis de ácidos nucleicos múltiplex, espacialmente distinguidos de especímenes biológicos |
US10292397B2 (en) | 2015-05-28 | 2019-05-21 | Marrone Bio Innovations, Inc. | Use of proteins to control molluscs |
BR112017027970A2 (pt) * | 2015-06-25 | 2018-08-28 | Amyris, Inc. | degrons dependentes de maltose, promotores responsivos à maltose, construtos de estabilização, e seu uso na produção de compostos não catabólicos |
JP2022501035A (ja) | 2018-09-25 | 2022-01-06 | モンサント テクノロジー エルエルシー | 新規の昆虫阻害タンパク質 |
BR112022021470A2 (pt) | 2020-05-01 | 2022-12-20 | Vestaron Corp | Combinações inseticidas |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0538496T3 (da) * | 1991-08-26 | 2004-02-23 | Baxter Healthcare Sa | Rekombinant fjerkrækoppevirus med intakt FPV tk-gen |
WO1999042589A2 (en) * | 1998-02-20 | 1999-08-26 | Novartis Pharma Ag. | Insecticidal toxins from photorhabdus |
-
2002
- 2002-02-07 KR KR10-2003-7010403A patent/KR20030085528A/ko not_active Application Discontinuation
- 2002-02-07 CA CA002434323A patent/CA2434323A1/en not_active Abandoned
- 2002-02-07 US US10/467,478 patent/US20070020625A1/en not_active Abandoned
- 2002-02-07 EP EP20020751498 patent/EP1379549A2/de not_active Withdrawn
- 2002-02-07 WO PCT/IB2002/003040 patent/WO2002094867A2/fr not_active Application Discontinuation
- 2002-02-07 AU AU2002339119A patent/AU2002339119A1/en not_active Abandoned
Non-Patent Citations (1)
Title |
---|
See references of WO02094867A2 * |
Also Published As
Publication number | Publication date |
---|---|
WO2002094867A8 (fr) | 2003-01-23 |
CA2434323A1 (en) | 2002-11-28 |
WO2002094867A2 (fr) | 2002-11-28 |
AU2002339119A1 (en) | 2002-12-03 |
KR20030085528A (ko) | 2003-11-05 |
US20070020625A1 (en) | 2007-01-25 |
WO2002094867A3 (fr) | 2003-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002094867A2 (fr) | Sequence du genome de photorhabdus luminescens souche tto1 et utilisations | |
US6562958B1 (en) | Nucleic acid and amino acid sequences relating to Acinetobacter baumannii for diagnostics and therapeutics | |
Doig et al. | Helicobacter pylori physiology predicted from genomic comparison of two strains | |
US7041814B1 (en) | Nucleic acid and amino acid sequences relating to Enterobacter cloacae for diagnostics and therapeutics | |
WO2005049642A2 (en) | Genome of legionella pneumophila paris and lens strain-diagnostic and epidemiological applications | |
Sanderson et al. | Genetic map of Salmonella typhimurium, edition VIII | |
US7090973B1 (en) | Nucleic acid sequences relating to Bacteroides fragilis for diagnostics and therapeutics | |
US8168417B2 (en) | Bacillus licheniformis chromosome | |
US8652773B2 (en) | Genes of an otitis media isolate of nontypeable Haemophilus influenza | |
US7060458B1 (en) | Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics | |
US20030054436A1 (en) | Staphylococcus aureus polynucleotides and sequences | |
US20060078901A1 (en) | Listeria monocytogenes genome, polypeptides and uses | |
US20100064393A1 (en) | Bacillus liceniformis chromosome | |
US6506581B1 (en) | Nucleotide sequence of the Haemophilus influenzae Rd genome, fragments thereof, and uses thereof | |
US6632636B1 (en) | Nucleic acids encoding 3-ketoacyl-ACP reductase from Moraxella catarrahalis | |
EP2601209A1 (de) | Genomik von actinoplanes utahensis | |
WO2001077334A2 (fr) | Genome de lactococcus lactis, polypeptides et utilisations | |
US20050131222A1 (en) | Nucleotide sequence of the haemophilus influenzae Rd genome, fragments thereof, and uses thereof | |
Barabote et al. | Comprehensive analysis of transport proteins encoded within the genome of Bdellovibrio bacteriovorus | |
US6528289B1 (en) | Nucleotide sequence of the Haemophilus influenzae Rd genome, fragments thereof, and uses thereof | |
Stephens | Genomic autobiographies of chlamydiae | |
US6632935B2 (en) | Genome DNA of bacterial symbiont of aphids | |
Lardi et al. | σ54-dependent response to nitrogen limitation and virulence in Burkholderia | |
Average | The genome sequence of the plant pathogen Xylella fastidiosa | |
Sittka et al. | Deep sequencing analysis of small noncoding RNA and mRNA |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20030818 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
17Q | First examination report despatched |
Effective date: 20040901 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20050312 |